Cellular and molecular mechanisms of recovery of rats from experimental autoimmune encephalomyelitis

Link to this page

info:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173035/RS//

Cellular and molecular mechanisms of recovery of rats from experimental autoimmune encephalomyelitis (en)
Ћелијски и молекулски механизми опоравка пацова од експерименталног аутоимунског енцефаломијелитиса (sr)
Ćelijski i molekulski mehanizmi oporavka pacova od eksperimentalnog autoimunskog encefalomijelitisa (sr_RS)
Authors

Publications

Uticaj donora vodonik-sulfida, morfolin-4-ium- 4-metoksifenil (morfolino)-fosfoditionata, na karakteristike imunskih ćelija uključenih u patogenezu eksperimentalnog autoimunskog encefalomijelitisa

Lazarević, Milica

(Belgrade: Faculty of Biology, University of Belgrade, 2021)

TY  - THES
AU  - Lazarević, Milica
PY  - 2021
UR  - http://radar.ibiss.bg.ac.rs/handle/123456789/4702
AB  - Multipla skleroza (MS) je hronična, inflamacijska, demijelinizujuća, neurodegenerativna bolest centralnog nervnog sistema. U cilju boljeg razumevanja faktora koji utiču na patogenezu MS-e, kao i definisanja novih potencijalnih terapeutika, u ovoj doktorskoj disertaciji je ispitivan efekat sporooslobađajućeg donora vodonik-sulfida, GYY4137, na imunske ćelije uključene u patogenezu eksperimentalnog autoimunskog encefalomijelitisa (EAE), najčešće korišćenog životinjskog modela MS-e. GYY4137 je ostvario jasan antiiflamacijski efekat na BV2 ćelije (ćelijska linija mikroglije), dok je njegov efekat na dendritske ćelije (DĆ) diferentovane iz ćelija kostne srži C57BL/6 miševa bio ograničen. Takođe, GYY4137 nije uticao na procentualnu zastupljenost Th1 i Th17 limfocita, glavnih patogenih populacija T limfocita u patogenezi EAE-a, unutar populacije ćelija poplitealnih limfnih čvorova (PLČ) imunizovanih C57BL/6 miševa i/ili DA pacova, ali je doveo do smanjenja zastupljenosti Th17 limfocita unutar populacije imunskih ćelija izolovanih iz kičmene moždine imunizovanih pacova. S druge strane, ovo jedinjenje je dovelo do smanjenja zastupljenosti regulatornih T limfocita (Treg) unutar populacije ćelija PLČ, ali nije uticalo na njihovu zastupljenost unutar populacije imunskih ćelija izolovanih iz kičmene moždine. Mehanizam kojim je GYY4137 ostvario efekat na zastupljenost Treg unutar populacije ćelija PLČ je obuhvatao smanjenje ekspresije transkripcionog faktora FoxP3, koje je najverovatnije bilo posredovano stimulacijom njegove proteazomalne degradacije. Pored toga, ovo jedinjenje je dovelo do povećanja produkcije reaktivnih vrsta kiseonika u BV2 ćelijama i CD4+ T limfocitima izolovanim iz PLČ imunizovanih miševa. Rezultati ove doktorske disertacije ukazuju na to da GYY4137 ostvaruje imunomodulacijski efekat na imunske ćelije uključene u patogenezu EAE-a, pri čemu priroda i intenzitet ovog efekta zavise od ćelijske populacije na koju se dejstvo ostvaruje, kao i od miljea iz kojeg ćelije potiču.
AB  - Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating, neurodegenerative disease of the central nervous system. The aim of this doctoral dissertation has been to improve knowledge about factors that influence MS pathogenesis and to define new potential MS therapeutics by examination of the effects of slow-releasing hydrogen-sulfide donor, GYY4137, on immune cells involved in the pathogenesis of experimental autoimmune encephalomyelitis (EAE), commonly used MS animal model. Immunomodulatory effect of in vitro treatment with GYY4137 was investigated on BV2 cells (microglial cell line) and dendritic cells (DC) differentiated from bone marrow precursors of C57BL/6 mice. GYY4137 exerted potent anti-inflammatory effects on BV2 cells, while its effects on DC were limited. Further, GYY4137 effect on the percentage of different T cell subpopulations among cells isolated from popliteal lymph nodes (PLN) or spinal cords of immunized C57BL/6 mice and/or DA rats was evaluated. The results showed that, despite having no effect on the percentage of two major pathogenic T helper (Th) cell populations in EAE (Th1 and Th17 cells) among cells from PLN, GYY4137 reduced the percentage of Th17 among immune cells isolated from spinal cords of immunized rats. In contrast to the effect on the percentage of Th17 cells, GYY4137 reduced the percentage of regulatory T cells (Treg) among PLN cells, but not among immune cells obtained from spinal cords of immunized rats. GYY4137 accomplished its effect on the Treg percentage by reducing the relative protein expression of FoxP3, which was probably mediated by stimulation of its proteasomal degradation. Furthermore, GYY4137 potentiated reactive oxygen species generation in BV2 cells and CD4+ T cells isolated from PLN of immunized mice. The results of this doctoral thesis indicate that GYY4137 exerts immunomodulatory effects on immune cells involved in EAE pathogenesis, while the nature and intensity of these effects depend on the cell type and the milieu of cellular origin. Also, these results suggest that GYY4137 has a significant anti-encephalitogenic potential.
PB  - Belgrade: Faculty of Biology, University of Belgrade
T2  - Faculty of Biology, University of Belgrade
T1  - Uticaj donora vodonik-sulfida, morfolin-4-ium- 4-metoksifenil (morfolino)-fosfoditionata, na karakteristike imunskih ćelija uključenih u patogenezu eksperimentalnog autoimunskog encefalomijelitisa
T1  - Effects of hydrogen-sulfide donor, morpholin-4-ium 4-methoxyphenyl (morpholino) phosphinodithioate, on immune cells involved in experimental autoimmune encephalomyelitis pathogenesis
SP  - 1
EP  - 109
UR  - https://hdl.handle.net/21.15107/rcub_ibiss_4702
ER  - 
@phdthesis{
author = "Lazarević, Milica",
year = "2021",
abstract = "Multipla skleroza (MS) je hronična, inflamacijska, demijelinizujuća, neurodegenerativna bolest centralnog nervnog sistema. U cilju boljeg razumevanja faktora koji utiču na patogenezu MS-e, kao i definisanja novih potencijalnih terapeutika, u ovoj doktorskoj disertaciji je ispitivan efekat sporooslobađajućeg donora vodonik-sulfida, GYY4137, na imunske ćelije uključene u patogenezu eksperimentalnog autoimunskog encefalomijelitisa (EAE), najčešće korišćenog životinjskog modela MS-e. GYY4137 je ostvario jasan antiiflamacijski efekat na BV2 ćelije (ćelijska linija mikroglije), dok je njegov efekat na dendritske ćelije (DĆ) diferentovane iz ćelija kostne srži C57BL/6 miševa bio ograničen. Takođe, GYY4137 nije uticao na procentualnu zastupljenost Th1 i Th17 limfocita, glavnih patogenih populacija T limfocita u patogenezi EAE-a, unutar populacije ćelija poplitealnih limfnih čvorova (PLČ) imunizovanih C57BL/6 miševa i/ili DA pacova, ali je doveo do smanjenja zastupljenosti Th17 limfocita unutar populacije imunskih ćelija izolovanih iz kičmene moždine imunizovanih pacova. S druge strane, ovo jedinjenje je dovelo do smanjenja zastupljenosti regulatornih T limfocita (Treg) unutar populacije ćelija PLČ, ali nije uticalo na njihovu zastupljenost unutar populacije imunskih ćelija izolovanih iz kičmene moždine. Mehanizam kojim je GYY4137 ostvario efekat na zastupljenost Treg unutar populacije ćelija PLČ je obuhvatao smanjenje ekspresije transkripcionog faktora FoxP3, koje je najverovatnije bilo posredovano stimulacijom njegove proteazomalne degradacije. Pored toga, ovo jedinjenje je dovelo do povećanja produkcije reaktivnih vrsta kiseonika u BV2 ćelijama i CD4+ T limfocitima izolovanim iz PLČ imunizovanih miševa. Rezultati ove doktorske disertacije ukazuju na to da GYY4137 ostvaruje imunomodulacijski efekat na imunske ćelije uključene u patogenezu EAE-a, pri čemu priroda i intenzitet ovog efekta zavise od ćelijske populacije na koju se dejstvo ostvaruje, kao i od miljea iz kojeg ćelije potiču., Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating, neurodegenerative disease of the central nervous system. The aim of this doctoral dissertation has been to improve knowledge about factors that influence MS pathogenesis and to define new potential MS therapeutics by examination of the effects of slow-releasing hydrogen-sulfide donor, GYY4137, on immune cells involved in the pathogenesis of experimental autoimmune encephalomyelitis (EAE), commonly used MS animal model. Immunomodulatory effect of in vitro treatment with GYY4137 was investigated on BV2 cells (microglial cell line) and dendritic cells (DC) differentiated from bone marrow precursors of C57BL/6 mice. GYY4137 exerted potent anti-inflammatory effects on BV2 cells, while its effects on DC were limited. Further, GYY4137 effect on the percentage of different T cell subpopulations among cells isolated from popliteal lymph nodes (PLN) or spinal cords of immunized C57BL/6 mice and/or DA rats was evaluated. The results showed that, despite having no effect on the percentage of two major pathogenic T helper (Th) cell populations in EAE (Th1 and Th17 cells) among cells from PLN, GYY4137 reduced the percentage of Th17 among immune cells isolated from spinal cords of immunized rats. In contrast to the effect on the percentage of Th17 cells, GYY4137 reduced the percentage of regulatory T cells (Treg) among PLN cells, but not among immune cells obtained from spinal cords of immunized rats. GYY4137 accomplished its effect on the Treg percentage by reducing the relative protein expression of FoxP3, which was probably mediated by stimulation of its proteasomal degradation. Furthermore, GYY4137 potentiated reactive oxygen species generation in BV2 cells and CD4+ T cells isolated from PLN of immunized mice. The results of this doctoral thesis indicate that GYY4137 exerts immunomodulatory effects on immune cells involved in EAE pathogenesis, while the nature and intensity of these effects depend on the cell type and the milieu of cellular origin. Also, these results suggest that GYY4137 has a significant anti-encephalitogenic potential.",
publisher = "Belgrade: Faculty of Biology, University of Belgrade",
journal = "Faculty of Biology, University of Belgrade",
title = "Uticaj donora vodonik-sulfida, morfolin-4-ium- 4-metoksifenil (morfolino)-fosfoditionata, na karakteristike imunskih ćelija uključenih u patogenezu eksperimentalnog autoimunskog encefalomijelitisa, Effects of hydrogen-sulfide donor, morpholin-4-ium 4-methoxyphenyl (morpholino) phosphinodithioate, on immune cells involved in experimental autoimmune encephalomyelitis pathogenesis",
pages = "1-109",
url = "https://hdl.handle.net/21.15107/rcub_ibiss_4702"
}
Lazarević, M.. (2021). Uticaj donora vodonik-sulfida, morfolin-4-ium- 4-metoksifenil (morfolino)-fosfoditionata, na karakteristike imunskih ćelija uključenih u patogenezu eksperimentalnog autoimunskog encefalomijelitisa. in Faculty of Biology, University of Belgrade
Belgrade: Faculty of Biology, University of Belgrade., 1-109.
https://hdl.handle.net/21.15107/rcub_ibiss_4702
Lazarević M. Uticaj donora vodonik-sulfida, morfolin-4-ium- 4-metoksifenil (morfolino)-fosfoditionata, na karakteristike imunskih ćelija uključenih u patogenezu eksperimentalnog autoimunskog encefalomijelitisa. in Faculty of Biology, University of Belgrade. 2021;:1-109.
https://hdl.handle.net/21.15107/rcub_ibiss_4702 .
Lazarević, Milica, "Uticaj donora vodonik-sulfida, morfolin-4-ium- 4-metoksifenil (morfolino)-fosfoditionata, na karakteristike imunskih ćelija uključenih u patogenezu eksperimentalnog autoimunskog encefalomijelitisa" in Faculty of Biology, University of Belgrade (2021):1-109,
https://hdl.handle.net/21.15107/rcub_ibiss_4702 .

MIF and insulin: Lifetime companions from common genesis to common pathogenesis

Stošić-Grujičić, Stanislava; Saksida, Tamara; Miljković, Đorđe; Stojanović, Ivana D.

(Elsevier, 2020)

TY  - JOUR
AU  - Stošić-Grujičić, Stanislava
AU  - Saksida, Tamara
AU  - Miljković, Đorđe
AU  - Stojanović, Ivana D.
PY  - 2020
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/3451
AB  - Pro-inflammatory nature of macrophage migration inhibitory factor (MIF) has been generally related to the
propagation of inflammatory and autoimmune diseases. But this molecule possesses many other peculiar
functions, unrelated to the immune system, among which is its supportive role in the post-translational modifications of insulin. In this way MIF enables proper insulin conformation within the pancreatic beta cell and its full activity. The inherent or acquired changes in MIF expression might therefore lead to different insulin processing and initiation of autoimmunity. The relation between MIF and insulin does not stop at this point; these two molecules continue to interact during pathological states characterized by inflammation and insulin resistance. In this context, MIF indirectly and negatively influences insulin action by boosting inflammatory environment and disabling target cells to respond to insulin. On the other side, insulin might interfere with MIF action as well, acting as an anti-inflammatory mediator. Therefore, the proper interaction between MIF and insulin is crucial for maintaining homeostasis, while anti-inflammatory therapies based on the systemic MIF blockage may disturb this balance. This review covers MIF-insulin relationship in the physiological and pathological conditions and discusses the approaches for MIF inhibition and their net effect specifically considering possible impact on insulin misfolding and the possible misinterpretation of previous results due to the discovery of MIF functional homolog D-dopachrome tautomerase.
PB  - Elsevier
T2  - Cytokine
T1  - MIF and insulin: Lifetime companions from common genesis to common pathogenesis
VL  - 125
DO  - 10.1016/j.cyto.2019.154792
SP  - 154792
ER  - 
@article{
author = "Stošić-Grujičić, Stanislava and Saksida, Tamara and Miljković, Đorđe and Stojanović, Ivana D.",
year = "2020",
abstract = "Pro-inflammatory nature of macrophage migration inhibitory factor (MIF) has been generally related to the
propagation of inflammatory and autoimmune diseases. But this molecule possesses many other peculiar
functions, unrelated to the immune system, among which is its supportive role in the post-translational modifications of insulin. In this way MIF enables proper insulin conformation within the pancreatic beta cell and its full activity. The inherent or acquired changes in MIF expression might therefore lead to different insulin processing and initiation of autoimmunity. The relation between MIF and insulin does not stop at this point; these two molecules continue to interact during pathological states characterized by inflammation and insulin resistance. In this context, MIF indirectly and negatively influences insulin action by boosting inflammatory environment and disabling target cells to respond to insulin. On the other side, insulin might interfere with MIF action as well, acting as an anti-inflammatory mediator. Therefore, the proper interaction between MIF and insulin is crucial for maintaining homeostasis, while anti-inflammatory therapies based on the systemic MIF blockage may disturb this balance. This review covers MIF-insulin relationship in the physiological and pathological conditions and discusses the approaches for MIF inhibition and their net effect specifically considering possible impact on insulin misfolding and the possible misinterpretation of previous results due to the discovery of MIF functional homolog D-dopachrome tautomerase.",
publisher = "Elsevier",
journal = "Cytokine",
title = "MIF and insulin: Lifetime companions from common genesis to common pathogenesis",
volume = "125",
doi = "10.1016/j.cyto.2019.154792",
pages = "154792"
}
Stošić-Grujičić, S., Saksida, T., Miljković, Đ.,& Stojanović, I. D.. (2020). MIF and insulin: Lifetime companions from common genesis to common pathogenesis. in Cytokine
Elsevier., 125, 154792.
https://doi.org/10.1016/j.cyto.2019.154792
Stošić-Grujičić S, Saksida T, Miljković Đ, Stojanović ID. MIF and insulin: Lifetime companions from common genesis to common pathogenesis. in Cytokine. 2020;125:154792.
doi:10.1016/j.cyto.2019.154792 .
Stošić-Grujičić, Stanislava, Saksida, Tamara, Miljković, Đorđe, Stojanović, Ivana D., "MIF and insulin: Lifetime companions from common genesis to common pathogenesis" in Cytokine, 125 (2020):154792,
https://doi.org/10.1016/j.cyto.2019.154792 . .
6
5
7

Comparison of dendritic cells obtained from autoimmunty-prone and resistant rats.

Nikolovski, Neda; Jevtić, Bojan; Mansilla, M. José; Petković, Filip; Blaževski, Jana; Timotijević, Gordana; Navarro-Barriuso, Juan; Martinez-Caceres, Eva; Mostarica Stojković, Marija; Miljković, Đorđe

(2019)

TY  - JOUR
AU  - Nikolovski, Neda
AU  - Jevtić, Bojan
AU  - Mansilla, M. José
AU  - Petković, Filip
AU  - Blaževski, Jana
AU  - Timotijević, Gordana
AU  - Navarro-Barriuso, Juan
AU  - Martinez-Caceres, Eva
AU  - Mostarica Stojković, Marija
AU  - Miljković, Đorđe
PY  - 2019
UR  - https://www.sciencedirect.com/science/article/pii/S0171298518302201?via%3Dihub
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/3265
AB  - Dendritic cells (DC) are responsible for the initiation and shaping of the adaptive immune response and are in the focus of autoimmunity research. We were interested in comparison of DC obtained from autoimmunity-prone Dark Agouti (DA) rats and autoimmunity-resistant Albino Oxford (AO) rats. DC were generated from bone marrow precursors and matured (mDC) by lipopolysaccharide. Tolerogenic DC (tolDC) obtained by vitamin D3 treatment were studied in parallel. Profile of cytokine production was different in AO and DA mDC and tolDC. Expression of MHC class II molecules and CD86 were higher in DA DC, while vitamin D3 reduced their expression in dendritic cells of both strains. Allogeneic proliferation of CD4+ T cells was reduced by AO tolDC, but not with DA tolDC in comparison to respective mDC. Finally, expression of various genes identified as differentially expressed in human mDC and tolDC was also analyzed in AO and DA DC. Again, AO and DA DC differed in the expression of the analyzed genes. To conclude, AO and DA DC differ in production of cytokines, expression of antigen presentation-related molecules and in regulation of CD4+ T proliferation. The difference is valuable for understanding the divergence of the strains in their susceptibility to autoimmunity.
T2  - Immunobiology
T1  - Comparison of dendritic cells obtained from autoimmunty-prone and resistant rats.
DO  - 10.1016/j.imbio.2019.01.001
ER  - 
@article{
author = "Nikolovski, Neda and Jevtić, Bojan and Mansilla, M. José and Petković, Filip and Blaževski, Jana and Timotijević, Gordana and Navarro-Barriuso, Juan and Martinez-Caceres, Eva and Mostarica Stojković, Marija and Miljković, Đorđe",
year = "2019",
abstract = "Dendritic cells (DC) are responsible for the initiation and shaping of the adaptive immune response and are in the focus of autoimmunity research. We were interested in comparison of DC obtained from autoimmunity-prone Dark Agouti (DA) rats and autoimmunity-resistant Albino Oxford (AO) rats. DC were generated from bone marrow precursors and matured (mDC) by lipopolysaccharide. Tolerogenic DC (tolDC) obtained by vitamin D3 treatment were studied in parallel. Profile of cytokine production was different in AO and DA mDC and tolDC. Expression of MHC class II molecules and CD86 were higher in DA DC, while vitamin D3 reduced their expression in dendritic cells of both strains. Allogeneic proliferation of CD4+ T cells was reduced by AO tolDC, but not with DA tolDC in comparison to respective mDC. Finally, expression of various genes identified as differentially expressed in human mDC and tolDC was also analyzed in AO and DA DC. Again, AO and DA DC differed in the expression of the analyzed genes. To conclude, AO and DA DC differ in production of cytokines, expression of antigen presentation-related molecules and in regulation of CD4+ T proliferation. The difference is valuable for understanding the divergence of the strains in their susceptibility to autoimmunity.",
journal = "Immunobiology",
title = "Comparison of dendritic cells obtained from autoimmunty-prone and resistant rats.",
doi = "10.1016/j.imbio.2019.01.001"
}
Nikolovski, N., Jevtić, B., Mansilla, M. J., Petković, F., Blaževski, J., Timotijević, G., Navarro-Barriuso, J., Martinez-Caceres, E., Mostarica Stojković, M.,& Miljković, Đ.. (2019). Comparison of dendritic cells obtained from autoimmunty-prone and resistant rats.. in Immunobiology.
https://doi.org/10.1016/j.imbio.2019.01.001
Nikolovski N, Jevtić B, Mansilla MJ, Petković F, Blaževski J, Timotijević G, Navarro-Barriuso J, Martinez-Caceres E, Mostarica Stojković M, Miljković Đ. Comparison of dendritic cells obtained from autoimmunty-prone and resistant rats.. in Immunobiology. 2019;.
doi:10.1016/j.imbio.2019.01.001 .
Nikolovski, Neda, Jevtić, Bojan, Mansilla, M. José, Petković, Filip, Blaževski, Jana, Timotijević, Gordana, Navarro-Barriuso, Juan, Martinez-Caceres, Eva, Mostarica Stojković, Marija, Miljković, Đorđe, "Comparison of dendritic cells obtained from autoimmunty-prone and resistant rats." in Immunobiology (2019),
https://doi.org/10.1016/j.imbio.2019.01.001 . .
1
3
3
3

Mehanizmi antiencefalitogenog dejstva etil-piruvata u eksperimentalnom autoimunskom encefalomijelitisu

Nikolovski, Neda

(Belgrade: University of Belgrade, Faculty of Biology, 2019)

TY  - THES
AU  - Nikolovski, Neda
PY  - 2019
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/3425
AB  - Multipla skleroza (MS) je hronična, inflamacijska, demijelinizirajuća bolest centralnog nervnog sistema (CNS-a). Autoimunski odgovor usmeren protiv CNS-a je bitan element patogeneze MS-e. Eksperimentalni autoimunski encefalomijelitis (EAE) predstavlja životinjski model MS-e pomoću kog se istražuju patogenetski mehanizmi ove bolesti. Glavne ćelije koje učestvuju u pokretanju autoimunskog odgovora usmerenog protiv CNS-a su antigen prezentujuće ćelije (APĆ) koje aktiviraju naivne CD4+ T-ćelije specifične za antigene CNS-a. Ove CD4+ T-ćelije se potom diferenciraju u efektorske Th1 (engl. T helper cells – Th ćelije) koje imaju sposobnost produkcije interferona γ (IFN-γ) i Th17 koje produkuju interleukin 17 (IL-17). Prolaskom kroz-krvno-moždanu barijeru, Th1 i Th17 ćelije dolaze u CNS gde ih reaktiviraju rezidentne APĆ, te one sva.ojim produktima privlače druge imunske ćelije u CNS, što sve dovodi do inflamacije koja vodi oštećenju tkiva CNS-a. Patogenezi bolesti doprinose i rezidentne ćelije CNS-a kao što su astrociti i mikroglija. Etil-piruvat (EP) je lipofilni estar pirogrožđane kiseline koji poseduje antioksidativna i antiinflamacijska svojstva. U ovoj studiji je ispitivan antiencefalitogeni efekat EP-a na tok EAE-a i ćelije ukjučene u patogenezu EAE-a. Takođe, ispitivan je i njegov in vitro i in vivo tolerogeni uticaj na dendritske ćelije (DĆ). Rezultati su pokazali da EP ostvaruje terapijsko dejstvo na EAE kada se daje pacovima svakodnevno, počev od pojave prvih kliničkih simptoma bolesti sve do njihovog inicijalnog oporavka. Svoj antiencefalitogeni efekat EP je ispoljio sprečavanjem infiltracije imunskih ćelija u CNS, inhibicijom produkcije IL-17 od strane CD4+ T-limfocita u kičmenoj moždini, čime je sprečio zapaljensku reakciju u CNS-u. EP je doveo i do redukcije broja reaktivnih makrofaga i ćelija mikroglije, kao i do inhibicije reaktivnosti astrocita. Takođe, sprečio je i oštećenje neurona. Jedan od mehanizama kojim je EP ostvario svoje dejstvo je inhibicija HMGB1 (grupa proteina visoke mobilnosti 1 (engl. High-mobility group box 1) u reaktivnim makrofagima/mikrogliji. Da EP ima i druge efekte na APĆ pokazali su rezultati na makrofagima, in vitro. EP je redukovao produkciju proinflamacijskih citokina od strane makrofaga i ekspresiju molekula bitnih za prezentaciju antigena na ovim ćelijama. Zatim, istraživanje je prošireno na DĆ kao profesionalne APĆ. Rezultati su pokazali da EP vrši tolerogeni uticaj na DĆ poreklom iz kostne srži miševa. Naime, tretman DĆ-a in vitro EP-om inhibira njihovu sposobnost efikasne prezentacije antigena, aktivacije T ćelija u alogenoj reakciji i produkcije proinflamacijskih citokina. Molekulski mehanizmi kojim EP ostvaruje svoje dejstvo na mišje DĆ, uključuju stimulaciju signalnog molekula nuklearnog faktora povezanog sa eritrocitima 2 (engl. Nuclear Factor Erythroid 2–related Factor 2-Nrf2) i enzima hem oksigenaze 1 (HO-1) i NQO1 (engl. NADPH-quinone oxidoreductase 1), kao i inhibiciju regulatornog proteina transkripcije nuklearnog faktora κB (NF-κB). EP-om tretirane DĆ ispoljavaju efekte in vivo inhibiranjem imunskog odgovora indukovanog kompletnim Frojndovim adjuvansom u miševa. Konačno, tolerogeno dejstvo EP-a pokazano je i na DĆ-ma diferenciranim iz monocita ljudi (engl. Monocyte derived Dendritic Cells - MoDĆ) dobrovoljnih davalaca krvi i pacijenata obolelih od MS-e. Iz rezultata ove doktorske disertacije proizilazi da je EP efikasno imunomodulacijsko jedinjenje koje inhibira EAE, kao i da je efikasno tolerogeno jedinjenje koje usmerava DĆ ka imunosupresivnom fenotipu. Samim tim, zaključuje se da EP ima potencijal da bude primenjen u terapiji MS-e. Primena EP bi mogla biti direktna ili u pripremi tolerogenih DĆ za ćelijsku imunoterapiju. Buduće predkliničke i kliničke studije bi trebalo da budu usmerene na istraživanje mogućnosti primene EP u terapiji MS-e, ali i drugih autoimunskih i hroničnih inflamacijskih bolesti. Ključne reči: eksperimentalni autoimunski encefalomijelitis, multipla skleroza, etil-piruvat, tolerogene dendritske ćelije Naučna oblast: Biologija Uža naučna oblast: Imunologija UDK broj: Anti-encephalitogenic mechanisms of ethyl pyruvate in experimental autoimmune encephalomyelitis Abstract Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the central nervous system (CNS) with proposed autoimmune pathogenesis. Experimental autoimmune encephalomyelitis (EAE) is an animal model of MS that is widely used to investigate pathogenetic mechanisms of the disease. Antigen presenting cells (APC) are major cells that are involved in the initiation of the autoimmune response against the CNS by activating CNS-specific naive CD4+ T cells. Consequently, these CD4+ T cells differentiate into effector T helper cells 1 (Th1) that produce interferon γ (IFN-γ) and Th17 cells that produce interleukin 17 (IL-17). Passing through the blood brain barrier, Th1 and Th17 cells arrive in the CNS where they become reactivated by the resident APC. Afterwards, other immune cells infiltrate the CNS, thus causing inflammation and tissue damage. The resident cells of the CNS, such as astrocytes and microglia, also contribute to the disease pathogenesis. Ethyl pyruvate (EP) is a lipophilic ester of pyruvic acid that possesses anti-oxidative and anti-inflammatory properties. The anti-encephalitogenic effect of EP in EAE and on cells of the CNS involved in the disease pathogenesis, were investigated in this study. Also, its in vitro and in vivo tolerogenic effect on dendritic cells (DC) was studied. Results showed that EP had a therapeutic effect on EAE when applied to the rats once a day, starting from the first clinical symptoms until their initial recovery. EP prevented immune cells infiltration into the CNS and inhibited T cell production of IL-17 in the spinal cord. Thus, EP restrained the inflammatory reaction in the CNS and therefore exerted its anti-encephalitogenic effect. Furthermore, treatment with EP led to the reduction of macrophages and microglia cell number, inhibition of astrocyte activity, as well as neuron destruction. Inhibition of HMGB1 (High-Mobility Group Box 1) molecule in activated macrophages/microglia was one of the mechanisms of the EP effects in the CNS. Moreover, in vitro treatment of stimulated macrophages with EP showed that EP had also an impact on APC. Treatment with EP led to reduced production of pro-inflammatory cytokines by macrophages as well as to downregulation of the expression of molecules relevant for antigen presentation. Furthermore, EP had a tolerogenic effect on the major APC, i.e. DC. Mice bone marrow derived DC were investigated. In vitro treatment of DC with EP inhibited their ability to efficiently present antigens, to activate T cells in allogeneic reaction, and to produce pro-inflammatory cytokines. Molecular mechanisms involved in the tolerogenic effects of EP on mice DC included stimulation of nuclear factor erythroid 2–related factor 2 (Nrf2) signaling, increase of heme oxygenase-1 (HO1) and NADPH-quinone oxidoreductase 1 (NQO1) expression, and inhibition of nuclear factor κB (NF-κB) transcription factor activation. Also, EP-treated DC inhibited immune response in vivo induced with complete Freund’s adjuvant in mice. Finally, the tolerogenic effects of EP were demonstrated in human monocyte derived DC (MoDC) obtained from healthy individuals and MS patients. Results of this doctoral thesis show that EP ameliorates EAE and that is also an effective tolerogenic agent that shifts DC towards immune-suppressing phenotype. Thereby, EP has the potential to be applied in MS therapy. Its application could be direct or through generation of tolerogenic DC as a mean of cell-based immunotherapy. Future preclinical and clinical studies should be focused towards investigating the possible application of EP in MS therapy, as well as in other autoimmune and chronic inflammatory diseases.
AB  - Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the central nervous system (CNS) with proposed autoimmune pathogenesis. Experimental autoimmune encephalomyelitis (EAE) is an animal model of MS that is widely used to investigate pathogenetic mechanisms of the disease. Antigen presenting cells (APC) are major cells that are involved in the initiation of the autoimmune response against the CNS by activating CNS-specific naive CD4+ T cells. Consequently, these CD4+ T cells differentiate into effector T helper cells 1 (Th1) that produce interferon γ (IFN-γ) and Th17 cells that produce interleukin 17 (IL-17). Passing through the blood brain barrier, Th1 and Th17 cells arrive in the CNS where they become reactivated by the resident APC. Afterwards, other immune cells infiltrate the CNS, thus causing inflammation and tissue damage. The resident cells of the CNS, such as astrocytes and microglia, also contribute to the disease pathogenesis. Ethyl pyruvate (EP) is a lipophilic ester of pyruvic acid that possesses anti-oxidative and anti-inflammatory properties. The anti-encephalitogenic effect of EP in EAE and on cells of the CNS involved in the disease pathogenesis, were investigated in this study. Also, its in vitro and in vivo tolerogenic effect on dendritic cells (DC) was studied. Results showed that EP had a therapeutic effect on EAE when applied to the rats once a day, starting from the first clinical symptoms until their initial recovery. EP prevented immune cells infiltration into the CNS and inhibited T cell production of IL-17 in the spinal cord. Thus, EP restrained the inflammatory reaction in the CNS and therefore exerted its anti-encephalitogenic effect. Furthermore, treatment with EP led to the reduction of macrophages and microglia cell number, inhibition of astrocyte activity, as well as neuron destruction. Inhibition of HMGB1 (High-Mobility Group Box 1) molecule in activated macrophages/microglia was one of the mechanisms of the EP effects in the CNS. Moreover, in vitro treatment of stimulated macrophages with EP showed that EP had also an impact on APC. Treatment with EP led to reduced production of pro-inflammatory cytokines by macrophages as well as to downregulation of the expression of molecules relevant for antigen presentation. Furthermore, EP had a tolerogenic effect on the major APC, i.e. DC. Mice bone marrow derived DC were investigated. In vitro treatment of DC with EP inhibited their ability to efficiently present antigens, to activate T cells in allogeneic reaction, and to produce pro-inflammatory cytokines. Molecular mechanisms involved in the tolerogenic effects of EP on mice DC included stimulation of nuclear factor erythroid 2–related factor 2 (Nrf2) signaling, increase of heme oxygenase-1 (HO1) and NADPH-quinone oxidoreductase 1 (NQO1) expression, and inhibition of nuclear factor κB (NF-κB) transcription factor activation. Also, EP-treated DC inhibited immune response in vivo induced with complete Freund’s adjuvant in mice. Finally, the tolerogenic effects of EP were demonstrated in human monocyte derived DC (MoDC) obtained from healthy individuals and MS patients. Results of this doctoral thesis show that EP ameliorates EAE and that is also an effective tolerogenic agent that shifts DC towards immune-suppressing phenotype. Thereby, EP has the potential to be applied in MS therapy. Its application could be direct or through generation of tolerogenic DC as a mean of cell-based immunotherapy. Future preclinical and clinical studies should be focused towards investigating the possible application of EP in MS therapy, as well as in other autoimmune and chronic inflammatory diseases.
PB  - Belgrade: University of Belgrade, Faculty of Biology
T2  - University of Belgrade, Faculty of Biology
T1  - Mehanizmi antiencefalitogenog dejstva etil-piruvata u eksperimentalnom autoimunskom encefalomijelitisu
T1  - Anti-encephalitogenic mechanisms of ethyl pyruvate in experimental autoimmune encephalomyelitis
SP  - 1
EP  - 122
UR  - https://hdl.handle.net/21.15107/rcub_ibiss_3425
ER  - 
@phdthesis{
author = "Nikolovski, Neda",
year = "2019",
abstract = "Multipla skleroza (MS) je hronična, inflamacijska, demijelinizirajuća bolest centralnog nervnog sistema (CNS-a). Autoimunski odgovor usmeren protiv CNS-a je bitan element patogeneze MS-e. Eksperimentalni autoimunski encefalomijelitis (EAE) predstavlja životinjski model MS-e pomoću kog se istražuju patogenetski mehanizmi ove bolesti. Glavne ćelije koje učestvuju u pokretanju autoimunskog odgovora usmerenog protiv CNS-a su antigen prezentujuće ćelije (APĆ) koje aktiviraju naivne CD4+ T-ćelije specifične za antigene CNS-a. Ove CD4+ T-ćelije se potom diferenciraju u efektorske Th1 (engl. T helper cells – Th ćelije) koje imaju sposobnost produkcije interferona γ (IFN-γ) i Th17 koje produkuju interleukin 17 (IL-17). Prolaskom kroz-krvno-moždanu barijeru, Th1 i Th17 ćelije dolaze u CNS gde ih reaktiviraju rezidentne APĆ, te one sva.ojim produktima privlače druge imunske ćelije u CNS, što sve dovodi do inflamacije koja vodi oštećenju tkiva CNS-a. Patogenezi bolesti doprinose i rezidentne ćelije CNS-a kao što su astrociti i mikroglija. Etil-piruvat (EP) je lipofilni estar pirogrožđane kiseline koji poseduje antioksidativna i antiinflamacijska svojstva. U ovoj studiji je ispitivan antiencefalitogeni efekat EP-a na tok EAE-a i ćelije ukjučene u patogenezu EAE-a. Takođe, ispitivan je i njegov in vitro i in vivo tolerogeni uticaj na dendritske ćelije (DĆ). Rezultati su pokazali da EP ostvaruje terapijsko dejstvo na EAE kada se daje pacovima svakodnevno, počev od pojave prvih kliničkih simptoma bolesti sve do njihovog inicijalnog oporavka. Svoj antiencefalitogeni efekat EP je ispoljio sprečavanjem infiltracije imunskih ćelija u CNS, inhibicijom produkcije IL-17 od strane CD4+ T-limfocita u kičmenoj moždini, čime je sprečio zapaljensku reakciju u CNS-u. EP je doveo i do redukcije broja reaktivnih makrofaga i ćelija mikroglije, kao i do inhibicije reaktivnosti astrocita. Takođe, sprečio je i oštećenje neurona. Jedan od mehanizama kojim je EP ostvario svoje dejstvo je inhibicija HMGB1 (grupa proteina visoke mobilnosti 1 (engl. High-mobility group box 1) u reaktivnim makrofagima/mikrogliji. Da EP ima i druge efekte na APĆ pokazali su rezultati na makrofagima, in vitro. EP je redukovao produkciju proinflamacijskih citokina od strane makrofaga i ekspresiju molekula bitnih za prezentaciju antigena na ovim ćelijama. Zatim, istraživanje je prošireno na DĆ kao profesionalne APĆ. Rezultati su pokazali da EP vrši tolerogeni uticaj na DĆ poreklom iz kostne srži miševa. Naime, tretman DĆ-a in vitro EP-om inhibira njihovu sposobnost efikasne prezentacije antigena, aktivacije T ćelija u alogenoj reakciji i produkcije proinflamacijskih citokina. Molekulski mehanizmi kojim EP ostvaruje svoje dejstvo na mišje DĆ, uključuju stimulaciju signalnog molekula nuklearnog faktora povezanog sa eritrocitima 2 (engl. Nuclear Factor Erythroid 2–related Factor 2-Nrf2) i enzima hem oksigenaze 1 (HO-1) i NQO1 (engl. NADPH-quinone oxidoreductase 1), kao i inhibiciju regulatornog proteina transkripcije nuklearnog faktora κB (NF-κB). EP-om tretirane DĆ ispoljavaju efekte in vivo inhibiranjem imunskog odgovora indukovanog kompletnim Frojndovim adjuvansom u miševa. Konačno, tolerogeno dejstvo EP-a pokazano je i na DĆ-ma diferenciranim iz monocita ljudi (engl. Monocyte derived Dendritic Cells - MoDĆ) dobrovoljnih davalaca krvi i pacijenata obolelih od MS-e. Iz rezultata ove doktorske disertacije proizilazi da je EP efikasno imunomodulacijsko jedinjenje koje inhibira EAE, kao i da je efikasno tolerogeno jedinjenje koje usmerava DĆ ka imunosupresivnom fenotipu. Samim tim, zaključuje se da EP ima potencijal da bude primenjen u terapiji MS-e. Primena EP bi mogla biti direktna ili u pripremi tolerogenih DĆ za ćelijsku imunoterapiju. Buduće predkliničke i kliničke studije bi trebalo da budu usmerene na istraživanje mogućnosti primene EP u terapiji MS-e, ali i drugih autoimunskih i hroničnih inflamacijskih bolesti. Ključne reči: eksperimentalni autoimunski encefalomijelitis, multipla skleroza, etil-piruvat, tolerogene dendritske ćelije Naučna oblast: Biologija Uža naučna oblast: Imunologija UDK broj: Anti-encephalitogenic mechanisms of ethyl pyruvate in experimental autoimmune encephalomyelitis Abstract Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the central nervous system (CNS) with proposed autoimmune pathogenesis. Experimental autoimmune encephalomyelitis (EAE) is an animal model of MS that is widely used to investigate pathogenetic mechanisms of the disease. Antigen presenting cells (APC) are major cells that are involved in the initiation of the autoimmune response against the CNS by activating CNS-specific naive CD4+ T cells. Consequently, these CD4+ T cells differentiate into effector T helper cells 1 (Th1) that produce interferon γ (IFN-γ) and Th17 cells that produce interleukin 17 (IL-17). Passing through the blood brain barrier, Th1 and Th17 cells arrive in the CNS where they become reactivated by the resident APC. Afterwards, other immune cells infiltrate the CNS, thus causing inflammation and tissue damage. The resident cells of the CNS, such as astrocytes and microglia, also contribute to the disease pathogenesis. Ethyl pyruvate (EP) is a lipophilic ester of pyruvic acid that possesses anti-oxidative and anti-inflammatory properties. The anti-encephalitogenic effect of EP in EAE and on cells of the CNS involved in the disease pathogenesis, were investigated in this study. Also, its in vitro and in vivo tolerogenic effect on dendritic cells (DC) was studied. Results showed that EP had a therapeutic effect on EAE when applied to the rats once a day, starting from the first clinical symptoms until their initial recovery. EP prevented immune cells infiltration into the CNS and inhibited T cell production of IL-17 in the spinal cord. Thus, EP restrained the inflammatory reaction in the CNS and therefore exerted its anti-encephalitogenic effect. Furthermore, treatment with EP led to the reduction of macrophages and microglia cell number, inhibition of astrocyte activity, as well as neuron destruction. Inhibition of HMGB1 (High-Mobility Group Box 1) molecule in activated macrophages/microglia was one of the mechanisms of the EP effects in the CNS. Moreover, in vitro treatment of stimulated macrophages with EP showed that EP had also an impact on APC. Treatment with EP led to reduced production of pro-inflammatory cytokines by macrophages as well as to downregulation of the expression of molecules relevant for antigen presentation. Furthermore, EP had a tolerogenic effect on the major APC, i.e. DC. Mice bone marrow derived DC were investigated. In vitro treatment of DC with EP inhibited their ability to efficiently present antigens, to activate T cells in allogeneic reaction, and to produce pro-inflammatory cytokines. Molecular mechanisms involved in the tolerogenic effects of EP on mice DC included stimulation of nuclear factor erythroid 2–related factor 2 (Nrf2) signaling, increase of heme oxygenase-1 (HO1) and NADPH-quinone oxidoreductase 1 (NQO1) expression, and inhibition of nuclear factor κB (NF-κB) transcription factor activation. Also, EP-treated DC inhibited immune response in vivo induced with complete Freund’s adjuvant in mice. Finally, the tolerogenic effects of EP were demonstrated in human monocyte derived DC (MoDC) obtained from healthy individuals and MS patients. Results of this doctoral thesis show that EP ameliorates EAE and that is also an effective tolerogenic agent that shifts DC towards immune-suppressing phenotype. Thereby, EP has the potential to be applied in MS therapy. Its application could be direct or through generation of tolerogenic DC as a mean of cell-based immunotherapy. Future preclinical and clinical studies should be focused towards investigating the possible application of EP in MS therapy, as well as in other autoimmune and chronic inflammatory diseases., Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the central nervous system (CNS) with proposed autoimmune pathogenesis. Experimental autoimmune encephalomyelitis (EAE) is an animal model of MS that is widely used to investigate pathogenetic mechanisms of the disease. Antigen presenting cells (APC) are major cells that are involved in the initiation of the autoimmune response against the CNS by activating CNS-specific naive CD4+ T cells. Consequently, these CD4+ T cells differentiate into effector T helper cells 1 (Th1) that produce interferon γ (IFN-γ) and Th17 cells that produce interleukin 17 (IL-17). Passing through the blood brain barrier, Th1 and Th17 cells arrive in the CNS where they become reactivated by the resident APC. Afterwards, other immune cells infiltrate the CNS, thus causing inflammation and tissue damage. The resident cells of the CNS, such as astrocytes and microglia, also contribute to the disease pathogenesis. Ethyl pyruvate (EP) is a lipophilic ester of pyruvic acid that possesses anti-oxidative and anti-inflammatory properties. The anti-encephalitogenic effect of EP in EAE and on cells of the CNS involved in the disease pathogenesis, were investigated in this study. Also, its in vitro and in vivo tolerogenic effect on dendritic cells (DC) was studied. Results showed that EP had a therapeutic effect on EAE when applied to the rats once a day, starting from the first clinical symptoms until their initial recovery. EP prevented immune cells infiltration into the CNS and inhibited T cell production of IL-17 in the spinal cord. Thus, EP restrained the inflammatory reaction in the CNS and therefore exerted its anti-encephalitogenic effect. Furthermore, treatment with EP led to the reduction of macrophages and microglia cell number, inhibition of astrocyte activity, as well as neuron destruction. Inhibition of HMGB1 (High-Mobility Group Box 1) molecule in activated macrophages/microglia was one of the mechanisms of the EP effects in the CNS. Moreover, in vitro treatment of stimulated macrophages with EP showed that EP had also an impact on APC. Treatment with EP led to reduced production of pro-inflammatory cytokines by macrophages as well as to downregulation of the expression of molecules relevant for antigen presentation. Furthermore, EP had a tolerogenic effect on the major APC, i.e. DC. Mice bone marrow derived DC were investigated. In vitro treatment of DC with EP inhibited their ability to efficiently present antigens, to activate T cells in allogeneic reaction, and to produce pro-inflammatory cytokines. Molecular mechanisms involved in the tolerogenic effects of EP on mice DC included stimulation of nuclear factor erythroid 2–related factor 2 (Nrf2) signaling, increase of heme oxygenase-1 (HO1) and NADPH-quinone oxidoreductase 1 (NQO1) expression, and inhibition of nuclear factor κB (NF-κB) transcription factor activation. Also, EP-treated DC inhibited immune response in vivo induced with complete Freund’s adjuvant in mice. Finally, the tolerogenic effects of EP were demonstrated in human monocyte derived DC (MoDC) obtained from healthy individuals and MS patients. Results of this doctoral thesis show that EP ameliorates EAE and that is also an effective tolerogenic agent that shifts DC towards immune-suppressing phenotype. Thereby, EP has the potential to be applied in MS therapy. Its application could be direct or through generation of tolerogenic DC as a mean of cell-based immunotherapy. Future preclinical and clinical studies should be focused towards investigating the possible application of EP in MS therapy, as well as in other autoimmune and chronic inflammatory diseases.",
publisher = "Belgrade: University of Belgrade, Faculty of Biology",
journal = "University of Belgrade, Faculty of Biology",
title = "Mehanizmi antiencefalitogenog dejstva etil-piruvata u eksperimentalnom autoimunskom encefalomijelitisu, Anti-encephalitogenic mechanisms of ethyl pyruvate in experimental autoimmune encephalomyelitis",
pages = "1-122",
url = "https://hdl.handle.net/21.15107/rcub_ibiss_3425"
}
Nikolovski, N.. (2019). Mehanizmi antiencefalitogenog dejstva etil-piruvata u eksperimentalnom autoimunskom encefalomijelitisu. in University of Belgrade, Faculty of Biology
Belgrade: University of Belgrade, Faculty of Biology., 1-122.
https://hdl.handle.net/21.15107/rcub_ibiss_3425
Nikolovski N. Mehanizmi antiencefalitogenog dejstva etil-piruvata u eksperimentalnom autoimunskom encefalomijelitisu. in University of Belgrade, Faculty of Biology. 2019;:1-122.
https://hdl.handle.net/21.15107/rcub_ibiss_3425 .
Nikolovski, Neda, "Mehanizmi antiencefalitogenog dejstva etil-piruvata u eksperimentalnom autoimunskom encefalomijelitisu" in University of Belgrade, Faculty of Biology (2019):1-122,
https://hdl.handle.net/21.15107/rcub_ibiss_3425 .

Ethyl Pyruvate Induces Tolerogenic Dendritic Cells.

Nikolovski, Neda; Mansilla, María José; Jevtić, Bojan; Navarro-Barriuso, Juan; Saksida, Tamara; Martínez-Cáceres, Eva M.; Miljković, Đorđe

(2019)

TY  - JOUR
AU  - Nikolovski, Neda
AU  - Mansilla, María José
AU  - Jevtić, Bojan
AU  - Navarro-Barriuso, Juan
AU  - Saksida, Tamara
AU  - Martínez-Cáceres, Eva M.
AU  - Miljković, Đorđe
PY  - 2019
UR  - https://www.frontiersin.org/article/10.3389/fimmu.2019.00157/full
UR  - http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC6374627
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/3280
AB  - Dendritic cells (DC) are professional antigen presenting cells that have a key role in shaping the immune response. Tolerogenic DC (tolDC) have immuno-regulatory properties and they are a promising prospective therapy for multiple sclerosis and other autoimmune diseases. Ethyl pyruvate (EP) is a redox analog of dimethyl fumarate (Tecfidera), a drug for multiple sclerosis treatment. We have recently shown that EP ameliorates experimental autoimmune encephalomyelitis, a multiple sclerosis murine model. Here, we expanded our study to its tolerogenic effects on DC. Phenotypic analysis has shown that DC obtained from mice or humans reduce expression of molecules required for T cell activation such as CD86, CD83, and HLA-DR under the influence of EP, while CD11c expression and viability of DC are not affected. Furthermore, EP-treated DC restrain proliferation and modulate cytokine production of allogeneic lymphocytes. These results demonstrate that EP has the ability to direct DC toward tolDC.
T2  - Frontiers in Immunology
T1  - Ethyl Pyruvate Induces Tolerogenic Dendritic Cells.
VL  - 10
DO  - 10.3389/fimmu.2019.00157
SP  - 157
ER  - 
@article{
author = "Nikolovski, Neda and Mansilla, María José and Jevtić, Bojan and Navarro-Barriuso, Juan and Saksida, Tamara and Martínez-Cáceres, Eva M. and Miljković, Đorđe",
year = "2019",
abstract = "Dendritic cells (DC) are professional antigen presenting cells that have a key role in shaping the immune response. Tolerogenic DC (tolDC) have immuno-regulatory properties and they are a promising prospective therapy for multiple sclerosis and other autoimmune diseases. Ethyl pyruvate (EP) is a redox analog of dimethyl fumarate (Tecfidera), a drug for multiple sclerosis treatment. We have recently shown that EP ameliorates experimental autoimmune encephalomyelitis, a multiple sclerosis murine model. Here, we expanded our study to its tolerogenic effects on DC. Phenotypic analysis has shown that DC obtained from mice or humans reduce expression of molecules required for T cell activation such as CD86, CD83, and HLA-DR under the influence of EP, while CD11c expression and viability of DC are not affected. Furthermore, EP-treated DC restrain proliferation and modulate cytokine production of allogeneic lymphocytes. These results demonstrate that EP has the ability to direct DC toward tolDC.",
journal = "Frontiers in Immunology",
title = "Ethyl Pyruvate Induces Tolerogenic Dendritic Cells.",
volume = "10",
doi = "10.3389/fimmu.2019.00157",
pages = "157"
}
Nikolovski, N., Mansilla, M. J., Jevtić, B., Navarro-Barriuso, J., Saksida, T., Martínez-Cáceres, E. M.,& Miljković, Đ.. (2019). Ethyl Pyruvate Induces Tolerogenic Dendritic Cells.. in Frontiers in Immunology, 10, 157.
https://doi.org/10.3389/fimmu.2019.00157
Nikolovski N, Mansilla MJ, Jevtić B, Navarro-Barriuso J, Saksida T, Martínez-Cáceres EM, Miljković Đ. Ethyl Pyruvate Induces Tolerogenic Dendritic Cells.. in Frontiers in Immunology. 2019;10:157.
doi:10.3389/fimmu.2019.00157 .
Nikolovski, Neda, Mansilla, María José, Jevtić, Bojan, Navarro-Barriuso, Juan, Saksida, Tamara, Martínez-Cáceres, Eva M., Miljković, Đorđe, "Ethyl Pyruvate Induces Tolerogenic Dendritic Cells." in Frontiers in Immunology, 10 (2019):157,
https://doi.org/10.3389/fimmu.2019.00157 . .
1
15
11
14

Oral neonatal antibiotic treatment perturbs gut microbiota and aggravates central nervous system autoimmunity in Dark Agouti rats.

Stanisavljević, Suzana; Čepić, Aleksa; Bojić, Svetlana; Veljović, Katarina; Mihajlović, Sanja; Nikolovski, Neda; Jevtić, Bojan; Momčilović, Miljana; Lazarević, Milica; Mostarica Stojković, Marija; Miljković, Đorđe; Golić, Nataša

(2019)

TY  - JOUR
AU  - Stanisavljević, Suzana
AU  - Čepić, Aleksa
AU  - Bojić, Svetlana
AU  - Veljović, Katarina
AU  - Mihajlović, Sanja
AU  - Nikolovski, Neda
AU  - Jevtić, Bojan
AU  - Momčilović, Miljana
AU  - Lazarević, Milica
AU  - Mostarica Stojković, Marija
AU  - Miljković, Đorđe
AU  - Golić, Nataša
PY  - 2019
UR  - http://www.nature.com/articles/s41598-018-37505-7
UR  - http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC6351648
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/3264
AB  - Gut microbiota dysbiosis has been considered the essential element in the pathogenesis of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE). Antibiotics were administered orally to Dark Agouti (DA) rats early in their life with the aim of perturbing gut microbiota and investigating the effects of such intervention on the course of EAE. As a result, the diversity of the gut microbiota was reduced under the influence of antibiotics. Mainly, Firmicutes and Actinobacteria were replaced by Proteobacteria and Bacteroidetes, while decreased proportions of Clostridia and Bacilli classes were accompanied by an increase in Gamma-Proteobacteria in antibiotic-treated animals. Interestingly, a notable decrease in the Helicobacteraceae, Spirochaetaceae and Turicibacteriaceae was scored in antibiotic-treated groups. Also, levels of short chain fatty acids were reduced in the faeces of antibiotic-treated rats. Consequently, aggravation of EAE, paralleled with stronger immune response in lymph nodes draining the site of immunization, and increased inflammation within the CNS, were observed in antibiotic-treated DA rats. Thus, the alteration of gut microbiota leads to an escalation of CNS-directed autoimmunity in DA rats. The results of this study indicate that antibiotic use in early life may have subsequent unfavourable effects on the regulation of the immune system.
T2  - Scientific Reports
T1  - Oral neonatal antibiotic treatment perturbs gut microbiota and aggravates central nervous system autoimmunity in Dark Agouti rats.
IS  - 1
VL  - 9
DO  - 10.1038/s41598-018-37505-7
SP  - 918
ER  - 
@article{
author = "Stanisavljević, Suzana and Čepić, Aleksa and Bojić, Svetlana and Veljović, Katarina and Mihajlović, Sanja and Nikolovski, Neda and Jevtić, Bojan and Momčilović, Miljana and Lazarević, Milica and Mostarica Stojković, Marija and Miljković, Đorđe and Golić, Nataša",
year = "2019",
abstract = "Gut microbiota dysbiosis has been considered the essential element in the pathogenesis of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE). Antibiotics were administered orally to Dark Agouti (DA) rats early in their life with the aim of perturbing gut microbiota and investigating the effects of such intervention on the course of EAE. As a result, the diversity of the gut microbiota was reduced under the influence of antibiotics. Mainly, Firmicutes and Actinobacteria were replaced by Proteobacteria and Bacteroidetes, while decreased proportions of Clostridia and Bacilli classes were accompanied by an increase in Gamma-Proteobacteria in antibiotic-treated animals. Interestingly, a notable decrease in the Helicobacteraceae, Spirochaetaceae and Turicibacteriaceae was scored in antibiotic-treated groups. Also, levels of short chain fatty acids were reduced in the faeces of antibiotic-treated rats. Consequently, aggravation of EAE, paralleled with stronger immune response in lymph nodes draining the site of immunization, and increased inflammation within the CNS, were observed in antibiotic-treated DA rats. Thus, the alteration of gut microbiota leads to an escalation of CNS-directed autoimmunity in DA rats. The results of this study indicate that antibiotic use in early life may have subsequent unfavourable effects on the regulation of the immune system.",
journal = "Scientific Reports",
title = "Oral neonatal antibiotic treatment perturbs gut microbiota and aggravates central nervous system autoimmunity in Dark Agouti rats.",
number = "1",
volume = "9",
doi = "10.1038/s41598-018-37505-7",
pages = "918"
}
Stanisavljević, S., Čepić, A., Bojić, S., Veljović, K., Mihajlović, S., Nikolovski, N., Jevtić, B., Momčilović, M., Lazarević, M., Mostarica Stojković, M., Miljković, Đ.,& Golić, N.. (2019). Oral neonatal antibiotic treatment perturbs gut microbiota and aggravates central nervous system autoimmunity in Dark Agouti rats.. in Scientific Reports, 9(1), 918.
https://doi.org/10.1038/s41598-018-37505-7
Stanisavljević S, Čepić A, Bojić S, Veljović K, Mihajlović S, Nikolovski N, Jevtić B, Momčilović M, Lazarević M, Mostarica Stojković M, Miljković Đ, Golić N. Oral neonatal antibiotic treatment perturbs gut microbiota and aggravates central nervous system autoimmunity in Dark Agouti rats.. in Scientific Reports. 2019;9(1):918.
doi:10.1038/s41598-018-37505-7 .
Stanisavljević, Suzana, Čepić, Aleksa, Bojić, Svetlana, Veljović, Katarina, Mihajlović, Sanja, Nikolovski, Neda, Jevtić, Bojan, Momčilović, Miljana, Lazarević, Milica, Mostarica Stojković, Marija, Miljković, Đorđe, Golić, Nataša, "Oral neonatal antibiotic treatment perturbs gut microbiota and aggravates central nervous system autoimmunity in Dark Agouti rats." in Scientific Reports, 9, no. 1 (2019):918,
https://doi.org/10.1038/s41598-018-37505-7 . .
15
29
15
29

Synthetic Tubulysin Derivative, Tubugi-1, Against Invasive Melanoma Cells: The Cell Death Triangle.

Drača, Dijana; Mijatović, Sanja; Krajnović, Tamara; Kaluđerović, Goran N; Wessjohann, Ludger A; Maksimović-Ivanić, Danijela

(2019)

TY  - JOUR
AU  - Drača, Dijana
AU  - Mijatović, Sanja
AU  - Krajnović, Tamara
AU  - Kaluđerović, Goran N
AU  - Wessjohann, Ludger A
AU  - Maksimović-Ivanić, Danijela
PY  - 2019
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/3484
UR  - http://ar.iiarjournals.org/content/39/10/5403
AB  - BACKGROUND/AIM Tubugi-1 is a more stable and accessible synthetic counterpart of natural tubulysins. This study aimed to evaluate its cytotoxic potential against anaplastic human melanoma cells. MATERIALS AND METHODS The viability of A-375 cells was determined by 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and crystal violet assay. The type of cell death and proliferative rate were investigated using flow cytometry and fluorescent microscopy, while the molecular background was evaluated by western blot. RESULTS Tubugi-1 reduced the viability of A-375 cells, inducing massive micronucleation, followed by augmented expression of inhibitor of nuclear factor-κB and caspase-2, typical of a mitotic catastrophe. Disturbed proliferation and G2M block with prominent caspase activity, weakened the expression of B-cell lymphoma 2 and B-cell lymphoma 2-associated X transient up-regulation, coexisted with intensive autophagy. Specific inhibition of autophagy by chloroquine resulted in conversion from mitotic catastrophe to rapid apoptosis. CONCLUSION Multilevel anticancer action of tubugi-1 is extended by co-application of an autophagy inhibitor, giving a new dimension in further preclinical advancement of this potential agent.
T2  - Anticancer Research
T1  - Synthetic Tubulysin Derivative, Tubugi-1, Against Invasive Melanoma Cells: The Cell Death Triangle.
IS  - 10
VL  - 39
DO  - 10.21873/anticanres.13734
SP  - 5403
EP  - 5415
ER  - 
@article{
author = "Drača, Dijana and Mijatović, Sanja and Krajnović, Tamara and Kaluđerović, Goran N and Wessjohann, Ludger A and Maksimović-Ivanić, Danijela",
year = "2019",
abstract = "BACKGROUND/AIM Tubugi-1 is a more stable and accessible synthetic counterpart of natural tubulysins. This study aimed to evaluate its cytotoxic potential against anaplastic human melanoma cells. MATERIALS AND METHODS The viability of A-375 cells was determined by 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and crystal violet assay. The type of cell death and proliferative rate were investigated using flow cytometry and fluorescent microscopy, while the molecular background was evaluated by western blot. RESULTS Tubugi-1 reduced the viability of A-375 cells, inducing massive micronucleation, followed by augmented expression of inhibitor of nuclear factor-κB and caspase-2, typical of a mitotic catastrophe. Disturbed proliferation and G2M block with prominent caspase activity, weakened the expression of B-cell lymphoma 2 and B-cell lymphoma 2-associated X transient up-regulation, coexisted with intensive autophagy. Specific inhibition of autophagy by chloroquine resulted in conversion from mitotic catastrophe to rapid apoptosis. CONCLUSION Multilevel anticancer action of tubugi-1 is extended by co-application of an autophagy inhibitor, giving a new dimension in further preclinical advancement of this potential agent.",
journal = "Anticancer Research",
title = "Synthetic Tubulysin Derivative, Tubugi-1, Against Invasive Melanoma Cells: The Cell Death Triangle.",
number = "10",
volume = "39",
doi = "10.21873/anticanres.13734",
pages = "5403-5415"
}
Drača, D., Mijatović, S., Krajnović, T., Kaluđerović, G. N., Wessjohann, L. A.,& Maksimović-Ivanić, D.. (2019). Synthetic Tubulysin Derivative, Tubugi-1, Against Invasive Melanoma Cells: The Cell Death Triangle.. in Anticancer Research, 39(10), 5403-5415.
https://doi.org/10.21873/anticanres.13734
Drača D, Mijatović S, Krajnović T, Kaluđerović GN, Wessjohann LA, Maksimović-Ivanić D. Synthetic Tubulysin Derivative, Tubugi-1, Against Invasive Melanoma Cells: The Cell Death Triangle.. in Anticancer Research. 2019;39(10):5403-5415.
doi:10.21873/anticanres.13734 .
Drača, Dijana, Mijatović, Sanja, Krajnović, Tamara, Kaluđerović, Goran N, Wessjohann, Ludger A, Maksimović-Ivanić, Danijela, "Synthetic Tubulysin Derivative, Tubugi-1, Against Invasive Melanoma Cells: The Cell Death Triangle." in Anticancer Research, 39, no. 10 (2019):5403-5415,
https://doi.org/10.21873/anticanres.13734 . .
1
2
1
2

Gut Microbiota Confers Resistance of Albino Oxford Rats to the Induction of Experimental Autoimmune Encephalomyelitis.

Stanisavljević, Suzana; Dinić, Miroslav; Jevtić, Bojan; Nikolovski, Neda; Momčilović, Miljana; Đokić, Jelena; Golić, Nataša; Mostarica Stojković, Marija; Miljković, Đorđe

(2018)

TY  - JOUR
AU  - Stanisavljević, Suzana
AU  - Dinić, Miroslav
AU  - Jevtić, Bojan
AU  - Nikolovski, Neda
AU  - Momčilović, Miljana
AU  - Đokić, Jelena
AU  - Golić, Nataša
AU  - Mostarica Stojković, Marija
AU  - Miljković, Đorđe
PY  - 2018
UR  - http://journal.frontiersin.org/article/10.3389/fimmu.2018.00942/full
UR  - http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5942155
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/3056
AB  - Albino Oxford (AO) rats are extremely resistant to induction of experimental autoimmune encephalomyelitis (EAE). EAE is an animal model of multiple sclerosis, a chronic inflammatory disease of the central nervous system (CNS), with established autoimmune pathogenesis. The autoimmune response against the antigens of the CNS is initiated in the peripheral lymphoid tissues after immunization of AO rats with CNS antigens. Subsequently, limited infiltration of the CNS occurs, yet without clinical sequels. It has recently become increasingly appreciated that gut-associated lymphoid tissues (GALT) and gut microbiota play an important role in regulation and propagation of encephalitogenic immune response. Therefore, modulation of AO gut microbiota by antibiotics was performed in this study. The treatment altered composition of gut microbiota in AO rats and led to a reduction in the proportion of regulatory T cells in Peyer's patches, mesenteric lymph nodes, and in lymph nodes draining the site of immunization. Upregulation of interferon-γ and interleukin (IL)-17 production was observed in the draining lymph nodes. The treatment led to clinically manifested EAE in AO rats with more numerous infiltrates and higher production of IL-17 observed in the CNS. Importantly, transfer of AO gut microbiota into EAE-prone Dark Agouti rats ameliorated the disease. These results clearly imply that gut microbiota is an important factor in AO rat resistance to EAE and that gut microbiota transfer is an efficacious way to treat CNS autoimmunity. These findings also support the idea that gut microbiota modulation has a potential as a future treatment of multiple sclerosis.
T2  - Frontiers in Immunology
T1  - Gut Microbiota Confers Resistance of Albino Oxford Rats to the Induction of Experimental Autoimmune Encephalomyelitis.
VL  - 9
DO  - 10.3389/fimmu.2018.00942
SP  - 942
ER  - 
@article{
author = "Stanisavljević, Suzana and Dinić, Miroslav and Jevtić, Bojan and Nikolovski, Neda and Momčilović, Miljana and Đokić, Jelena and Golić, Nataša and Mostarica Stojković, Marija and Miljković, Đorđe",
year = "2018",
abstract = "Albino Oxford (AO) rats are extremely resistant to induction of experimental autoimmune encephalomyelitis (EAE). EAE is an animal model of multiple sclerosis, a chronic inflammatory disease of the central nervous system (CNS), with established autoimmune pathogenesis. The autoimmune response against the antigens of the CNS is initiated in the peripheral lymphoid tissues after immunization of AO rats with CNS antigens. Subsequently, limited infiltration of the CNS occurs, yet without clinical sequels. It has recently become increasingly appreciated that gut-associated lymphoid tissues (GALT) and gut microbiota play an important role in regulation and propagation of encephalitogenic immune response. Therefore, modulation of AO gut microbiota by antibiotics was performed in this study. The treatment altered composition of gut microbiota in AO rats and led to a reduction in the proportion of regulatory T cells in Peyer's patches, mesenteric lymph nodes, and in lymph nodes draining the site of immunization. Upregulation of interferon-γ and interleukin (IL)-17 production was observed in the draining lymph nodes. The treatment led to clinically manifested EAE in AO rats with more numerous infiltrates and higher production of IL-17 observed in the CNS. Importantly, transfer of AO gut microbiota into EAE-prone Dark Agouti rats ameliorated the disease. These results clearly imply that gut microbiota is an important factor in AO rat resistance to EAE and that gut microbiota transfer is an efficacious way to treat CNS autoimmunity. These findings also support the idea that gut microbiota modulation has a potential as a future treatment of multiple sclerosis.",
journal = "Frontiers in Immunology",
title = "Gut Microbiota Confers Resistance of Albino Oxford Rats to the Induction of Experimental Autoimmune Encephalomyelitis.",
volume = "9",
doi = "10.3389/fimmu.2018.00942",
pages = "942"
}
Stanisavljević, S., Dinić, M., Jevtić, B., Nikolovski, N., Momčilović, M., Đokić, J., Golić, N., Mostarica Stojković, M.,& Miljković, Đ.. (2018). Gut Microbiota Confers Resistance of Albino Oxford Rats to the Induction of Experimental Autoimmune Encephalomyelitis.. in Frontiers in Immunology, 9, 942.
https://doi.org/10.3389/fimmu.2018.00942
Stanisavljević S, Dinić M, Jevtić B, Nikolovski N, Momčilović M, Đokić J, Golić N, Mostarica Stojković M, Miljković Đ. Gut Microbiota Confers Resistance of Albino Oxford Rats to the Induction of Experimental Autoimmune Encephalomyelitis.. in Frontiers in Immunology. 2018;9:942.
doi:10.3389/fimmu.2018.00942 .
Stanisavljević, Suzana, Dinić, Miroslav, Jevtić, Bojan, Nikolovski, Neda, Momčilović, Miljana, Đokić, Jelena, Golić, Nataša, Mostarica Stojković, Marija, Miljković, Đorđe, "Gut Microbiota Confers Resistance of Albino Oxford Rats to the Induction of Experimental Autoimmune Encephalomyelitis." in Frontiers in Immunology, 9 (2018):942,
https://doi.org/10.3389/fimmu.2018.00942 . .
5
27
18
25

Uloga mikrobiote i limfnog tkiva creva u otpornosti pacova soja Albino Oksford na indukciju eksperimentalnog autoimunskog encefalomijelitisa

Stanisavljević, Suzana

(Belgrade: Universiy of Belgrade, Faculty of Biology, 2018)

TY  - THES
AU  - Stanisavljević, Suzana
PY  - 2018
UR  - http://uvidok.rcub.bg.ac.rs/handle/123456789/2612
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/3105
AB  - Multipla skleroza je hronična, inflamacijska, neurodegenerativna, demijelinizirajuća bolest centralnog nervnog sistema (CNS). Etiologija multiple skleroze još uvek nije poznata, ali je sve više podataka koji pokazuju ulogu crevne mikrobiote u patogenezi bolesti. Više podataka o značaju crevne mikrobiote u autoimunosti CNS dobijeno je istraživanjima na eksperimentalnom autoimunskom encefalomijelitisu (EAE), životinjskom modelu multiple skleroze. U EAE-u se autoimunski odgovor protiv CNS-a pokreće u limfnim čvorovima koji dreniraju mesto imunizacije, gde se CD4+ T ćelije specifične za antigene CNS-a aktiviraju i diferenciraju u Th (engl. T helper) 1 ćelije koje produkuju IFN-γ i Th17 ćelije koje produkuju IL-17. Kada dospeju u CNS ove Th ćelije bivaju reaktivirane od strane lokalnih antigen-prezentujućih ćelija. Nakon reaktivacije, encefalitogene Th ćelije pokreću i održavaju inflamaciju unutar CNS-a. Albino oksford (AO) pacovi su veoma otporni na indukciju EAE-a. S druge strane, Dark Agouti (DA) pacovi razvijaju EAE čak i nakon blage imunizacije. U dosadašnjim istraživanjima je pokazano da se AO pacovi u odnosu na DA pacove razlikuju po slaboj aktivaciji Th1 i Th17 ćelija u relevantnim limfnim čvorovima u odgovoru na encefalitogenu imunizaciju. Takođe, pokazano je da relativno mali broj encefalitogenih ćelija infiltrira CNS AO pacova. Do sada nije vršeno ispitivanje uloge GALT-a i mikrobiote creva u otpornosti pacova soja AO na indukciju EAE-a. Sve je više istraživanja koja pokazuju da mikroorganizmi creva imaju važnu ulogu u regulaciji imunskog odgovora kroz interakciju sa limfnim tkivom creva (GALT, engl. gut-associated lymphoid tissue). U istraživanjima na EAE-u je pokazano da određeni mikroorganizmi creva pospešuju tok bolesti, dok drugi ostvaruju terapeutske efekte modulacijom odnosa Th1 i Th17 encefalitogenih ćelija i regulatornih T ćelija (Treg). Poznato je i da encefalitogene CD4+ T ćelije migriraju u GALT, uključujući mezenterične limfne čvorove i Pejerove ploče gde se mogu diferencirati u Treg. Smatra se da značajnu ulogu u ovoj rediferencijaciji imaju crevne bakterije i njihovi produkti. Zbog toga je važno utvrditi koje bakterije u crevima i na koji način ostvaruju ulogu u patogenezi multiple skleroze, kako bi se modulacijom mikrobiote creva omogućila prevencija i tretman bolesti. Nedavna uporedna istraživanja sastava mikrobiote creva osoba obolelih od multiple skleroze i zdravih osoba pokazuju kod pacijenata povećanu ili smanjenu zastupljenost pojedinih grupa bakterija, uključujući Clostridia klaster XIV i IV, Bacteroides fragilis, i rodova Pseudomonas, Mycoplana, Haemophilus, Dorea i Blautia. Međutim, rezultati dosadašnjih istraživanja nisu dovoljni da bi bilo razjašnjeno na koji način mikrobiota creva doprinosi patogenezi multiple skleroze. Mikrobiota creva i GALT se smatraju važnim učesnicima u pokretanju, propagaciji, ali i u prevenciji autoimunoskih procesa u CNS-u. Sastav mikrobiote creva se razlikuje kod pacijenata obolelih od multiple skleroze i zdravih osoba. U skladu sa tim, soj pacova podložan EAE-u, DA, i soj koji je otporan na indukciju EAE-a, AO, pokazali su razlike u sastavu mikrobiote creva u ovom istraživanju. Konkretno, Turicibacter sp. i članovi Lachnospiraceae familije su identifikovani kao mogući promoteri otpornosti na indukciju EAE-a ili oporavka od EAE-a. Takođe je pokazano da se ćelijski sastav mezenteričnih limfnih čvorova, kao i ćelijski sastav Pejerovih ploča razlikuje između AO i DA pacova, s tim da DA pacovi imaju više CD4+ ćelija, ali i više Treg-a. Pored toga, ćelije GALT-a AO soja pacova otpornog na EAE su produkovale manje IFN-γ i IL-17 u poređenju sa DA sojem pacova koji je podložan indukciji EAE-a. Produkcija IL-10 kao glavnog imunoregulatornog citokina u crevima koji ispoljava imunosupresivne efekte, razlikovala se između ova dva soja pacova. Antibiotski tretman je narušio otpornost AO pacova prema indukciji EAE-a, što se ogledalo u pojavi blagih kliničkih simptoma, povećanom broju infiltrata u kičmenoj moždini i povišenom nivou IL-17 u CNS-u. Primena antibiotika je dovela i do promena u drenirajućim limfnim čvorovima. U njima je primećen povećan broj ćelija sa povećanom zastupljenošću CD4+ T ćelija, koje su, produkovale više proinflamacijskih citokina. Analiza zastupljenosti Treg je pokazala da se procenat Treg razlikuje između sojeva samo u Pejerovim pločama neimunizovanih životinja, dok se nakon imunizacije smanjuje udeo Treg u drenirajućim limfnim čvorovima, mezenteričnim limfnim čvorovima i Pejerovim pločama kod životinja tretiranih antibioticima. Sastav mikrobiote creva AO pacova se znatno promenio nakon četiri nedelje primene antibiotika, nakon čega su se promene izgubile. Transferom mikrobiote creva AO pacova u DA pacove došlo je do ublažavanja simptoma EAE-a kod DA pacova. U CNS-u dolazi do smanjenja koncentracije IL-17 kod tako tretiranih DA životinja. Uočena je povećana celularnost u drenirajućim limfnim čvorovima, kao i veća zastupljenost Treg u drenirajućim i mezenteričnim limfnim čvorovima. Transfer mikrobiote je doveo i do značajne promene diverziteta crevne mikrobiote tretiranih DA pacova. Promene se naročito zapažaju u diverzitetu mlečnokiselinskih bakterija. Rezultati ove doktrorske disertacije jasno pokazuju da crevna mikrobiota ima bitnu ulogu u patogenezi autoimunskog procesa prisutnog u CNS-u i da bi njena modulacija mogla biti novi pristup u terapiji multiple skleroze.
AB  - Multiple sclerosis is a chronic inflammatory neurodegenerative demyelinating disease of the central nervous system (CNS). Etiology of multiple sclerosis is still unknown, but data are showing that gut microbiota plays an important role in the pathogenesis of this disease. Information about the significance of gut microbiota in CNS autoimmunity has been dominantly obtained in studies in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. The autoimmune response against CNS starts in lymph nodes draining the site of immunization in EAE. There, CD4+ T cells are being activated and differentiated into Th1 (helper T cells) and Th17 cells that produce IFN-γ and IL-17, respectively. When Th cells arrive in the CNS, they are reactivated by local antigen-presenting cells. After the reactivation, these encephalitogenic T cells initiate and propagate CNS inflammation.
Albino Oxford (AO) rats are highly resistant to EAE induction. On the other hand, Dark Agouti (DA) rats develop EAE even after the mild immunization. In our earlier studies it was shown that AO rats had less activated Th1 and Th17 cells in the relevant lymph nodes in response to encephalitogenic immunization, unlike DA rats. Also, it was shown that relatively small number of encephalitogenic cells infiltrated CNS in AO rats. Up until now, the studies of role of GALT and gut microbiota in resistance of AO rats in EAE induction have not been conducted.
It has been increasingly appreciated that gut microbiota plays an important role in the regulation of the immune response through interaction with the cells of gut-associated lymphoid tissue (GALT). In EAE studies specific gut microorganisms have been proposed to promote the disease, while others have been shown to have therapeutic effects by modulating ratio and activity of encefalitogenic Th1 and Th17 cells and regulatory T cells (Treg). Encefalitogenic cells can also migrate to GALT, including mesenteric lymph nodes and Peyer’s patches, where they can be re-differentiated into
Treg. It is considered that intrinsic bacteria and their products play an important role in this re-differentiation. That is why it has become important to determine which bacteria and in what ways are implicated in multiple sclerosis pathogenesis, to prevent and treat the disease by modulating gut microbiota. Recent comparative studies of gut microbiota content of multiple sclerosis patients and healthy individuals have shown increased presence of some groups of bacteria in patients, including Clostridia clusters XIV and IV, Bacteroides fragilis, and Pseudomonas, Mycoplana, Haemophilus, Dorea, Blautia. However, the results of previous studies cannot clarify what are the mechanisms of contribution of gut microbiota to pathogenesis of multiple sclerosis.
Gut microbiota and GALT are considered to be important players in initiation, propagation, but also in prevention of CNS autoimmunity. Gut microbiota content differs among multiple sclerosis patients and healthy subjects. In accordance to that, EAE-resistant rat strain and EAE-prone rat strain have different gut microbiota content in our experiments. Specifically, Turicibacter sp. and members of Lachnospiraceae family are identified as possible promoters of EAE resistance or EAE recovery. Besides, it was demonstrated that mesenteric lymph nodes and Peyer’s patches differ between AO and DA rats. DA rats have higher proportion of CD4+ cells and more Tregs. Further, GALT cells of EAE-resistant rat strain produced less IFN-γ and IL-17 in comparison to EAE-prone rat strain. Production of IL-10, major immunoregulatory cytokine, was also different among these rat strains.
Antibiotic treatment disturbed EAE resistance in AO rats. It was observed in the form of mild clinical symptoms, higher number of spinal cord infiltrates and a higher concentration of IL-17 in the CNS. Antibiotic effects were seen in lymph nodes draining the site of immunization; they had higher cellularity, a higher proportion of CD4+ cells, and higher production of proinflammatory cytokines. Treg analysis showed that there was a difference in Peyer’s patches of unimmunized rats. After the immunization, less Treg was observed in draining lymph nodes, mesenteric lymph nodes and Peyer’s patches in antibiotic treated rats. Gut microbiota content of AO rats was significantly changed after four weeks of antibiotic treatment.
Gut microbiota transfer from AO rats into DA rats resulted in milder EAE symptoms in DA rats and lower concentration of IL-17 in CNS. Increased proportion of
Treg was observed in draining lymph nodes in the treated animals. Gut microbiota transfer led to more significant changes in gut microbiota diversity of treated rats, especially in lactic acid bacteria.
Results of this doctoral thesis clearly demonstrate important role of gut microbiota in the pathogenesis of the CNS autoimmunity. They also imply that modulation of gut microbiota could be used as a novel therapeutic approach in multiple sclerosis.
PB  - Belgrade: Universiy of Belgrade, Faculty of Biology
T2  - University of Belgrade, Faculty of Biology
T1  - Uloga mikrobiote i limfnog tkiva creva u otpornosti pacova soja Albino Oksford na indukciju eksperimentalnog autoimunskog encefalomijelitisa
T1  - Role of gut microbiota and gut-associated lymphoid tissue in resistance of Albino Oxford rats to experimental autoimmune encephalomyelitis induction
SP  - 1
EP  - 134
UR  - https://hdl.handle.net/21.15107/rcub_ibiss_3105
ER  - 
@phdthesis{
author = "Stanisavljević, Suzana",
year = "2018",
abstract = "Multipla skleroza je hronična, inflamacijska, neurodegenerativna, demijelinizirajuća bolest centralnog nervnog sistema (CNS). Etiologija multiple skleroze još uvek nije poznata, ali je sve više podataka koji pokazuju ulogu crevne mikrobiote u patogenezi bolesti. Više podataka o značaju crevne mikrobiote u autoimunosti CNS dobijeno je istraživanjima na eksperimentalnom autoimunskom encefalomijelitisu (EAE), životinjskom modelu multiple skleroze. U EAE-u se autoimunski odgovor protiv CNS-a pokreće u limfnim čvorovima koji dreniraju mesto imunizacije, gde se CD4+ T ćelije specifične za antigene CNS-a aktiviraju i diferenciraju u Th (engl. T helper) 1 ćelije koje produkuju IFN-γ i Th17 ćelije koje produkuju IL-17. Kada dospeju u CNS ove Th ćelije bivaju reaktivirane od strane lokalnih antigen-prezentujućih ćelija. Nakon reaktivacije, encefalitogene Th ćelije pokreću i održavaju inflamaciju unutar CNS-a. Albino oksford (AO) pacovi su veoma otporni na indukciju EAE-a. S druge strane, Dark Agouti (DA) pacovi razvijaju EAE čak i nakon blage imunizacije. U dosadašnjim istraživanjima je pokazano da se AO pacovi u odnosu na DA pacove razlikuju po slaboj aktivaciji Th1 i Th17 ćelija u relevantnim limfnim čvorovima u odgovoru na encefalitogenu imunizaciju. Takođe, pokazano je da relativno mali broj encefalitogenih ćelija infiltrira CNS AO pacova. Do sada nije vršeno ispitivanje uloge GALT-a i mikrobiote creva u otpornosti pacova soja AO na indukciju EAE-a. Sve je više istraživanja koja pokazuju da mikroorganizmi creva imaju važnu ulogu u regulaciji imunskog odgovora kroz interakciju sa limfnim tkivom creva (GALT, engl. gut-associated lymphoid tissue). U istraživanjima na EAE-u je pokazano da određeni mikroorganizmi creva pospešuju tok bolesti, dok drugi ostvaruju terapeutske efekte modulacijom odnosa Th1 i Th17 encefalitogenih ćelija i regulatornih T ćelija (Treg). Poznato je i da encefalitogene CD4+ T ćelije migriraju u GALT, uključujući mezenterične limfne čvorove i Pejerove ploče gde se mogu diferencirati u Treg. Smatra se da značajnu ulogu u ovoj rediferencijaciji imaju crevne bakterije i njihovi produkti. Zbog toga je važno utvrditi koje bakterije u crevima i na koji način ostvaruju ulogu u patogenezi multiple skleroze, kako bi se modulacijom mikrobiote creva omogućila prevencija i tretman bolesti. Nedavna uporedna istraživanja sastava mikrobiote creva osoba obolelih od multiple skleroze i zdravih osoba pokazuju kod pacijenata povećanu ili smanjenu zastupljenost pojedinih grupa bakterija, uključujući Clostridia klaster XIV i IV, Bacteroides fragilis, i rodova Pseudomonas, Mycoplana, Haemophilus, Dorea i Blautia. Međutim, rezultati dosadašnjih istraživanja nisu dovoljni da bi bilo razjašnjeno na koji način mikrobiota creva doprinosi patogenezi multiple skleroze. Mikrobiota creva i GALT se smatraju važnim učesnicima u pokretanju, propagaciji, ali i u prevenciji autoimunoskih procesa u CNS-u. Sastav mikrobiote creva se razlikuje kod pacijenata obolelih od multiple skleroze i zdravih osoba. U skladu sa tim, soj pacova podložan EAE-u, DA, i soj koji je otporan na indukciju EAE-a, AO, pokazali su razlike u sastavu mikrobiote creva u ovom istraživanju. Konkretno, Turicibacter sp. i članovi Lachnospiraceae familije su identifikovani kao mogući promoteri otpornosti na indukciju EAE-a ili oporavka od EAE-a. Takođe je pokazano da se ćelijski sastav mezenteričnih limfnih čvorova, kao i ćelijski sastav Pejerovih ploča razlikuje između AO i DA pacova, s tim da DA pacovi imaju više CD4+ ćelija, ali i više Treg-a. Pored toga, ćelije GALT-a AO soja pacova otpornog na EAE su produkovale manje IFN-γ i IL-17 u poređenju sa DA sojem pacova koji je podložan indukciji EAE-a. Produkcija IL-10 kao glavnog imunoregulatornog citokina u crevima koji ispoljava imunosupresivne efekte, razlikovala se između ova dva soja pacova. Antibiotski tretman je narušio otpornost AO pacova prema indukciji EAE-a, što se ogledalo u pojavi blagih kliničkih simptoma, povećanom broju infiltrata u kičmenoj moždini i povišenom nivou IL-17 u CNS-u. Primena antibiotika je dovela i do promena u drenirajućim limfnim čvorovima. U njima je primećen povećan broj ćelija sa povećanom zastupljenošću CD4+ T ćelija, koje su, produkovale više proinflamacijskih citokina. Analiza zastupljenosti Treg je pokazala da se procenat Treg razlikuje između sojeva samo u Pejerovim pločama neimunizovanih životinja, dok se nakon imunizacije smanjuje udeo Treg u drenirajućim limfnim čvorovima, mezenteričnim limfnim čvorovima i Pejerovim pločama kod životinja tretiranih antibioticima. Sastav mikrobiote creva AO pacova se znatno promenio nakon četiri nedelje primene antibiotika, nakon čega su se promene izgubile. Transferom mikrobiote creva AO pacova u DA pacove došlo je do ublažavanja simptoma EAE-a kod DA pacova. U CNS-u dolazi do smanjenja koncentracije IL-17 kod tako tretiranih DA životinja. Uočena je povećana celularnost u drenirajućim limfnim čvorovima, kao i veća zastupljenost Treg u drenirajućim i mezenteričnim limfnim čvorovima. Transfer mikrobiote je doveo i do značajne promene diverziteta crevne mikrobiote tretiranih DA pacova. Promene se naročito zapažaju u diverzitetu mlečnokiselinskih bakterija. Rezultati ove doktrorske disertacije jasno pokazuju da crevna mikrobiota ima bitnu ulogu u patogenezi autoimunskog procesa prisutnog u CNS-u i da bi njena modulacija mogla biti novi pristup u terapiji multiple skleroze., Multiple sclerosis is a chronic inflammatory neurodegenerative demyelinating disease of the central nervous system (CNS). Etiology of multiple sclerosis is still unknown, but data are showing that gut microbiota plays an important role in the pathogenesis of this disease. Information about the significance of gut microbiota in CNS autoimmunity has been dominantly obtained in studies in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. The autoimmune response against CNS starts in lymph nodes draining the site of immunization in EAE. There, CD4+ T cells are being activated and differentiated into Th1 (helper T cells) and Th17 cells that produce IFN-γ and IL-17, respectively. When Th cells arrive in the CNS, they are reactivated by local antigen-presenting cells. After the reactivation, these encephalitogenic T cells initiate and propagate CNS inflammation.
Albino Oxford (AO) rats are highly resistant to EAE induction. On the other hand, Dark Agouti (DA) rats develop EAE even after the mild immunization. In our earlier studies it was shown that AO rats had less activated Th1 and Th17 cells in the relevant lymph nodes in response to encephalitogenic immunization, unlike DA rats. Also, it was shown that relatively small number of encephalitogenic cells infiltrated CNS in AO rats. Up until now, the studies of role of GALT and gut microbiota in resistance of AO rats in EAE induction have not been conducted.
It has been increasingly appreciated that gut microbiota plays an important role in the regulation of the immune response through interaction with the cells of gut-associated lymphoid tissue (GALT). In EAE studies specific gut microorganisms have been proposed to promote the disease, while others have been shown to have therapeutic effects by modulating ratio and activity of encefalitogenic Th1 and Th17 cells and regulatory T cells (Treg). Encefalitogenic cells can also migrate to GALT, including mesenteric lymph nodes and Peyer’s patches, where they can be re-differentiated into
Treg. It is considered that intrinsic bacteria and their products play an important role in this re-differentiation. That is why it has become important to determine which bacteria and in what ways are implicated in multiple sclerosis pathogenesis, to prevent and treat the disease by modulating gut microbiota. Recent comparative studies of gut microbiota content of multiple sclerosis patients and healthy individuals have shown increased presence of some groups of bacteria in patients, including Clostridia clusters XIV and IV, Bacteroides fragilis, and Pseudomonas, Mycoplana, Haemophilus, Dorea, Blautia. However, the results of previous studies cannot clarify what are the mechanisms of contribution of gut microbiota to pathogenesis of multiple sclerosis.
Gut microbiota and GALT are considered to be important players in initiation, propagation, but also in prevention of CNS autoimmunity. Gut microbiota content differs among multiple sclerosis patients and healthy subjects. In accordance to that, EAE-resistant rat strain and EAE-prone rat strain have different gut microbiota content in our experiments. Specifically, Turicibacter sp. and members of Lachnospiraceae family are identified as possible promoters of EAE resistance or EAE recovery. Besides, it was demonstrated that mesenteric lymph nodes and Peyer’s patches differ between AO and DA rats. DA rats have higher proportion of CD4+ cells and more Tregs. Further, GALT cells of EAE-resistant rat strain produced less IFN-γ and IL-17 in comparison to EAE-prone rat strain. Production of IL-10, major immunoregulatory cytokine, was also different among these rat strains.
Antibiotic treatment disturbed EAE resistance in AO rats. It was observed in the form of mild clinical symptoms, higher number of spinal cord infiltrates and a higher concentration of IL-17 in the CNS. Antibiotic effects were seen in lymph nodes draining the site of immunization; they had higher cellularity, a higher proportion of CD4+ cells, and higher production of proinflammatory cytokines. Treg analysis showed that there was a difference in Peyer’s patches of unimmunized rats. After the immunization, less Treg was observed in draining lymph nodes, mesenteric lymph nodes and Peyer’s patches in antibiotic treated rats. Gut microbiota content of AO rats was significantly changed after four weeks of antibiotic treatment.
Gut microbiota transfer from AO rats into DA rats resulted in milder EAE symptoms in DA rats and lower concentration of IL-17 in CNS. Increased proportion of
Treg was observed in draining lymph nodes in the treated animals. Gut microbiota transfer led to more significant changes in gut microbiota diversity of treated rats, especially in lactic acid bacteria.
Results of this doctoral thesis clearly demonstrate important role of gut microbiota in the pathogenesis of the CNS autoimmunity. They also imply that modulation of gut microbiota could be used as a novel therapeutic approach in multiple sclerosis.",
publisher = "Belgrade: Universiy of Belgrade, Faculty of Biology",
journal = "University of Belgrade, Faculty of Biology",
title = "Uloga mikrobiote i limfnog tkiva creva u otpornosti pacova soja Albino Oksford na indukciju eksperimentalnog autoimunskog encefalomijelitisa, Role of gut microbiota and gut-associated lymphoid tissue in resistance of Albino Oxford rats to experimental autoimmune encephalomyelitis induction",
pages = "1-134",
url = "https://hdl.handle.net/21.15107/rcub_ibiss_3105"
}
Stanisavljević, S.. (2018). Uloga mikrobiote i limfnog tkiva creva u otpornosti pacova soja Albino Oksford na indukciju eksperimentalnog autoimunskog encefalomijelitisa. in University of Belgrade, Faculty of Biology
Belgrade: Universiy of Belgrade, Faculty of Biology., 1-134.
https://hdl.handle.net/21.15107/rcub_ibiss_3105
Stanisavljević S. Uloga mikrobiote i limfnog tkiva creva u otpornosti pacova soja Albino Oksford na indukciju eksperimentalnog autoimunskog encefalomijelitisa. in University of Belgrade, Faculty of Biology. 2018;:1-134.
https://hdl.handle.net/21.15107/rcub_ibiss_3105 .
Stanisavljević, Suzana, "Uloga mikrobiote i limfnog tkiva creva u otpornosti pacova soja Albino Oksford na indukciju eksperimentalnog autoimunskog encefalomijelitisa" in University of Belgrade, Faculty of Biology (2018):1-134,
https://hdl.handle.net/21.15107/rcub_ibiss_3105 .

Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells.

Basile, Maria Sofia; Mazzon, Emanuela; Krajnović, Tamara; Drača, Dijana; Cavalli, Eugenio; Al-Abed, Yousef; Bramanti, Placido; Nicoletti, Ferdinando; Mijatović, Sanja; Maksimović-Ivanić, Danijela

(2018)

TY  - JOUR
AU  - Basile, Maria Sofia
AU  - Mazzon, Emanuela
AU  - Krajnović, Tamara
AU  - Drača, Dijana
AU  - Cavalli, Eugenio
AU  - Al-Abed, Yousef
AU  - Bramanti, Placido
AU  - Nicoletti, Ferdinando
AU  - Mijatović, Sanja
AU  - Maksimović-Ivanić, Danijela
PY  - 2018
UR  - internal-pdf://Basile et al. - 2018 - Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells.pdf
UR  - http://www.mdpi.com/1420-3049/23/10/2463
UR  - http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC6222694
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/3216
AB  - Glioblastoma (GBM) is the most frequent and deadly form of primary malignant brain tumor among adults. A promising emerging approach for GBM treatment may be offered from HIV protease inhibitors (HIV-PIs). In fact, in addition to their primary pharmacological activity in the treatment of HIV infection, they possess important anti-neoplastic effects. According to previous studies, the addition of a nitric oxide (NO) donating group to parental compounds can reduce their toxicity and enhance the anticancer action of various compounds, including HIV-PIs. In this study we compared the effects of the HIV-PI Lopinavir (Lopi) and of its NO-derivative Lopinavir-NO (Lopi-NO) on the in vitro growth of LN-229 and U-251 human GBM cell lines. Lopi-NO reduced the viability of LN-229 and U-251 cells at significantly lower concentrations than the parental drug. In particular, Lopi-NO inhibited tumor cell proliferation and induced the differentiation of U-251 cells toward an astrocyte-like phenotype without triggering significant cell death in both cell types. The anticancer effect of Lopi-NO was persistent even upon drug removal. Furthermore, Lopi-NO induced strong autophagy that did not appear to be related to its chemotherapeutic action. Overall, our results suggest that Lopi-NO could be a potential effective anticancer drug for GBM treatment.
T2  - Molecules (Basel, Switzerland)
T2  - Molecules (Basel, Switzerland)
T1  - Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells.
IS  - 10
VL  - 23
DO  - 10.3390/molecules23102463
SP  - 2463
ER  - 
@article{
author = "Basile, Maria Sofia and Mazzon, Emanuela and Krajnović, Tamara and Drača, Dijana and Cavalli, Eugenio and Al-Abed, Yousef and Bramanti, Placido and Nicoletti, Ferdinando and Mijatović, Sanja and Maksimović-Ivanić, Danijela",
year = "2018",
abstract = "Glioblastoma (GBM) is the most frequent and deadly form of primary malignant brain tumor among adults. A promising emerging approach for GBM treatment may be offered from HIV protease inhibitors (HIV-PIs). In fact, in addition to their primary pharmacological activity in the treatment of HIV infection, they possess important anti-neoplastic effects. According to previous studies, the addition of a nitric oxide (NO) donating group to parental compounds can reduce their toxicity and enhance the anticancer action of various compounds, including HIV-PIs. In this study we compared the effects of the HIV-PI Lopinavir (Lopi) and of its NO-derivative Lopinavir-NO (Lopi-NO) on the in vitro growth of LN-229 and U-251 human GBM cell lines. Lopi-NO reduced the viability of LN-229 and U-251 cells at significantly lower concentrations than the parental drug. In particular, Lopi-NO inhibited tumor cell proliferation and induced the differentiation of U-251 cells toward an astrocyte-like phenotype without triggering significant cell death in both cell types. The anticancer effect of Lopi-NO was persistent even upon drug removal. Furthermore, Lopi-NO induced strong autophagy that did not appear to be related to its chemotherapeutic action. Overall, our results suggest that Lopi-NO could be a potential effective anticancer drug for GBM treatment.",
journal = "Molecules (Basel, Switzerland), Molecules (Basel, Switzerland)",
title = "Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells.",
number = "10",
volume = "23",
doi = "10.3390/molecules23102463",
pages = "2463"
}
Basile, M. S., Mazzon, E., Krajnović, T., Drača, D., Cavalli, E., Al-Abed, Y., Bramanti, P., Nicoletti, F., Mijatović, S.,& Maksimović-Ivanić, D.. (2018). Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells.. in Molecules (Basel, Switzerland), 23(10), 2463.
https://doi.org/10.3390/molecules23102463
Basile MS, Mazzon E, Krajnović T, Drača D, Cavalli E, Al-Abed Y, Bramanti P, Nicoletti F, Mijatović S, Maksimović-Ivanić D. Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells.. in Molecules (Basel, Switzerland). 2018;23(10):2463.
doi:10.3390/molecules23102463 .
Basile, Maria Sofia, Mazzon, Emanuela, Krajnović, Tamara, Drača, Dijana, Cavalli, Eugenio, Al-Abed, Yousef, Bramanti, Placido, Nicoletti, Ferdinando, Mijatović, Sanja, Maksimović-Ivanić, Danijela, "Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells." in Molecules (Basel, Switzerland), 23, no. 10 (2018):2463,
https://doi.org/10.3390/molecules23102463 . .
2
38
33
35

The H₂S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide.

Lazarević, Milica; Mazzon, Emanuela; Momčilović, Miljana; Basile, Maria Sofia; Colletti, Giuseppe; Petralia, Maria Cristina; Bramanti, Placido; Nicoletti, Ferdinando; Miljković, Đorđe

(2018)

TY  - JOUR
AU  - Lazarević, Milica
AU  - Mazzon, Emanuela
AU  - Momčilović, Miljana
AU  - Basile, Maria Sofia
AU  - Colletti, Giuseppe
AU  - Petralia, Maria Cristina
AU  - Bramanti, Placido
AU  - Nicoletti, Ferdinando
AU  - Miljković, Đorđe
PY  - 2018
UR  - http://www.mdpi.com/1420-3049/23/11/2966
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/3191
AB  - GYY4137 is a hydrogen sulfide (H₂S) donor that has been shown to act in an anti-inflammatory manner in vitro and in vivo. Microglial cells are among the major players in immunoinflammatory, degenerative, and neoplastic disorders of the central nervous system, including multiple sclerosis, Parkinson's disease, Alzheimer's disease, and glioblastoma multiforme. So far, the effects of GYY4137 on microglial cells have not been thoroughly investigated. In this study, BV2 microglial cells were stimulated with interferon-gamma and lipopolysaccharide and treated with GYY4137. The agent did not influence the viability of BV2 cells in concentrations up to 200 μM. It inhibited tumor necrosis factor but not interleukin-6 production. Expression of CD40 and CD86 were reduced under the influence of the donor. The phagocytic ability of BV2 cells and nitric oxide production were also affected by the agent. Surprisingly, GYY4137 upregulated generation of reactive oxygen species (ROS) by BV2 cells. The effect was mimicked by another H₂S donor, Na₂S, and it was not reproduced in macrophages. Our results demonstrate that GYY4137 downregulates inflammatory properties of BV2 cells but increases their ability to generate ROS. Further investigation of this unexpected phenomenon is warranted.
T2  - Molecules (Basel, Switzerland)
T1  - The H₂S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide.
IS  - 11
VL  - 23
DO  - 10.3390/molecules23112966
SP  - 2966
ER  - 
@article{
author = "Lazarević, Milica and Mazzon, Emanuela and Momčilović, Miljana and Basile, Maria Sofia and Colletti, Giuseppe and Petralia, Maria Cristina and Bramanti, Placido and Nicoletti, Ferdinando and Miljković, Đorđe",
year = "2018",
abstract = "GYY4137 is a hydrogen sulfide (H₂S) donor that has been shown to act in an anti-inflammatory manner in vitro and in vivo. Microglial cells are among the major players in immunoinflammatory, degenerative, and neoplastic disorders of the central nervous system, including multiple sclerosis, Parkinson's disease, Alzheimer's disease, and glioblastoma multiforme. So far, the effects of GYY4137 on microglial cells have not been thoroughly investigated. In this study, BV2 microglial cells were stimulated with interferon-gamma and lipopolysaccharide and treated with GYY4137. The agent did not influence the viability of BV2 cells in concentrations up to 200 μM. It inhibited tumor necrosis factor but not interleukin-6 production. Expression of CD40 and CD86 were reduced under the influence of the donor. The phagocytic ability of BV2 cells and nitric oxide production were also affected by the agent. Surprisingly, GYY4137 upregulated generation of reactive oxygen species (ROS) by BV2 cells. The effect was mimicked by another H₂S donor, Na₂S, and it was not reproduced in macrophages. Our results demonstrate that GYY4137 downregulates inflammatory properties of BV2 cells but increases their ability to generate ROS. Further investigation of this unexpected phenomenon is warranted.",
journal = "Molecules (Basel, Switzerland)",
title = "The H₂S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide.",
number = "11",
volume = "23",
doi = "10.3390/molecules23112966",
pages = "2966"
}
Lazarević, M., Mazzon, E., Momčilović, M., Basile, M. S., Colletti, G., Petralia, M. C., Bramanti, P., Nicoletti, F.,& Miljković, Đ.. (2018). The H₂S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide.. in Molecules (Basel, Switzerland), 23(11), 2966.
https://doi.org/10.3390/molecules23112966
Lazarević M, Mazzon E, Momčilović M, Basile MS, Colletti G, Petralia MC, Bramanti P, Nicoletti F, Miljković Đ. The H₂S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide.. in Molecules (Basel, Switzerland). 2018;23(11):2966.
doi:10.3390/molecules23112966 .
Lazarević, Milica, Mazzon, Emanuela, Momčilović, Miljana, Basile, Maria Sofia, Colletti, Giuseppe, Petralia, Maria Cristina, Bramanti, Placido, Nicoletti, Ferdinando, Miljković, Đorđe, "The H₂S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide." in Molecules (Basel, Switzerland), 23, no. 11 (2018):2966,
https://doi.org/10.3390/molecules23112966 . .
22
14
20

Uticaj različitih ekstrakata krastavca (Cucumis sativus L. cv. Chinese long) na encefalitogeni potencijal T limfocita pacova u eksperimentalnom autoimunskom encefalomijelitisu

Jevtić, Bojan

(Belgrade: University of Belgrade, Faculty of Biology, 2018)

TY  - THES
AU  - Jevtić, Bojan
PY  - 2018
UR  - http://uvidok.rcub.bg.ac.rs/handle/123456789/2609
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/3104
AB  - Eksperimentalni autoimunski encefalomijelitis (EAE) je model multiple skleroze (MS), hronične inflamatorne bolesti centralnog nervnog sistema (CNS). Osnovne patogene populacije u EAE su efektorski T limfociti koji produkuju interferon-γ (Th1) ili interleukin-17 (Th17) i aktivirani makrofagi koji dovode do oštećenja CNS. Imajući u vidu da krastavac (Cucumis sativus) predstavlja bogat izvor sekundarnih metabolita kao što su polifenoli i kukurbitacini, u ovoj studiji je po prvi put ispitivano dejstvo različitih ekstrakata krastavca na encefalitogeni potencijal T limfocita, efektorske funkcije makrofaga i antigen-prezentujuću aktivnost dendritskih ćelija (DĆ). Rezultati su pokazali da ekstrakt lista krastavca (ELK) ostvaruje najpotentnije dejstvo, inhibirajući produkciju IFN-γ i IL-17 od strane encefalitogenih T limfocita, modulišući signalne puteve Nf-κB i p38 (MAPK). Pored toga, ELK je ostvario inhibitorno dejstvo na efektorske funkcije makrofaga i antigen-prezentujuću aktivnost DĆ u koncentracijama koje nisu pokazale citotoksičnost na embrione zebrice (Danio rerio) in vivo. Dalje, ELK je uspešno inhibirao encefalitogene T limfocite nakon in vivo primene u EAE. Kvantitativna i kvalitativna analiza ELK metodom masene spektrometrije potvrdila je prisustvo 37 različitih jedinjenja od kojih su kukurbitacini bili najzastupljenija jedinjenja. Shodno tome, ispitana su i imunomodulacijska dejstva kukurbitacina B i kukurbitacina E na glavnim imunskim ćelijama uključenim u patogenezu EAE. Ova ispitivanja su potvrdila dejstva ELK, sugerišući da su kukurbitacini, kao glavni konstituenti ovog ekstrakta, barem delimično odgovorni za ostvarena dejstva ELK. Rezultati ove doktorske disertacije ukazuju na to da ekstrakt lista krastavca i kukurbitacini ostvaruju snažne antiencefalitogene efekte u modelu EAE i ukazuju na važnost dodatnih istraživanja u cilju pronalaženja odgovarajućih tretmana autoimunosti CNS.
AB  - Experimental autoimmune encephalomyelitis (EAE) is an animal model of multiple sclerosis (MS), a chronic inflammatory disease of the central nervous system (CNS). T lymphocytes, which produce interferon-γ (Th1) or interleukin-17 (Th17), and activated macrophages, that lead to CNS damage, are the major pathogenic cell populations in EAE. Having in mind that cucumber (Cucumis sativus) is a rich source of secondary metabolites such as polyphenols and cucurbitacins, in this study, for the first time, the effects of various cucumber extracts were investigated on encephalytogenic T lymphocytes, effector function of macrophages and antigen-presenting activities of dendritic cells (DC). The results show that cucumber leaf extract (CLE) expresses the most potent effect by inhibiting the production of IFN-γ and IL-17 in encephalytogenic T lymphocytes, through modulation of signaling pathways Nf-κB and p38 (MAPK). Additionally, CLE imposes an inhibitory effect on the effector functions of macrophages and antigen-presenting activity of DC in concentrations that do not show cytotoxicity in zebrafish (Danio rerio) in vivo. Also, CLE inhibits generation of encephalitogenic cells in vivo. Phytochemical analysis of CLE, characterized by mass spectrometry, confirmed the presence of 37 different compounds, among which cucurbitacins were the most abundant compounds. Hence, the immunomodulatory effects of cucurbitacin B and cucurbitacin E were also examined on the major immune cells involved in EAE pathogenesis. The obtained results confirm the effects of CLE, suggesting that cucurbitacins are, at least partially, responsible for its effects. The results of this doctoral dissertation indicate that the cucumber leaf extract and its major constituents cucurbitacins have anti-encephalitogenic effects in the EAE model, Moreover, they suggest the importance of additional research towards novel highly efficient CNS autoimmunity treatments.
PB  - Belgrade: University of Belgrade, Faculty of Biology
T2  - University of Belgrade, Faculty of Biology
T1  - Uticaj različitih ekstrakata krastavca (Cucumis sativus L. cv. Chinese long) na encefalitogeni potencijal T limfocita pacova u eksperimentalnom autoimunskom encefalomijelitisu
T1  - Effects of different Cucumber extracts (Cucumis sativus L. cv. Chinese long) on the encephalitogenic pontential of T lymphocytes in experimental autoimmune encephalomyelitis
SP  - 1
EP  - 141
UR  - https://hdl.handle.net/21.15107/rcub_ibiss_3104
ER  - 
@phdthesis{
author = "Jevtić, Bojan",
year = "2018",
abstract = "Eksperimentalni autoimunski encefalomijelitis (EAE) je model multiple skleroze (MS), hronične inflamatorne bolesti centralnog nervnog sistema (CNS). Osnovne patogene populacije u EAE su efektorski T limfociti koji produkuju interferon-γ (Th1) ili interleukin-17 (Th17) i aktivirani makrofagi koji dovode do oštećenja CNS. Imajući u vidu da krastavac (Cucumis sativus) predstavlja bogat izvor sekundarnih metabolita kao što su polifenoli i kukurbitacini, u ovoj studiji je po prvi put ispitivano dejstvo različitih ekstrakata krastavca na encefalitogeni potencijal T limfocita, efektorske funkcije makrofaga i antigen-prezentujuću aktivnost dendritskih ćelija (DĆ). Rezultati su pokazali da ekstrakt lista krastavca (ELK) ostvaruje najpotentnije dejstvo, inhibirajući produkciju IFN-γ i IL-17 od strane encefalitogenih T limfocita, modulišući signalne puteve Nf-κB i p38 (MAPK). Pored toga, ELK je ostvario inhibitorno dejstvo na efektorske funkcije makrofaga i antigen-prezentujuću aktivnost DĆ u koncentracijama koje nisu pokazale citotoksičnost na embrione zebrice (Danio rerio) in vivo. Dalje, ELK je uspešno inhibirao encefalitogene T limfocite nakon in vivo primene u EAE. Kvantitativna i kvalitativna analiza ELK metodom masene spektrometrije potvrdila je prisustvo 37 različitih jedinjenja od kojih su kukurbitacini bili najzastupljenija jedinjenja. Shodno tome, ispitana su i imunomodulacijska dejstva kukurbitacina B i kukurbitacina E na glavnim imunskim ćelijama uključenim u patogenezu EAE. Ova ispitivanja su potvrdila dejstva ELK, sugerišući da su kukurbitacini, kao glavni konstituenti ovog ekstrakta, barem delimično odgovorni za ostvarena dejstva ELK. Rezultati ove doktorske disertacije ukazuju na to da ekstrakt lista krastavca i kukurbitacini ostvaruju snažne antiencefalitogene efekte u modelu EAE i ukazuju na važnost dodatnih istraživanja u cilju pronalaženja odgovarajućih tretmana autoimunosti CNS., Experimental autoimmune encephalomyelitis (EAE) is an animal model of multiple sclerosis (MS), a chronic inflammatory disease of the central nervous system (CNS). T lymphocytes, which produce interferon-γ (Th1) or interleukin-17 (Th17), and activated macrophages, that lead to CNS damage, are the major pathogenic cell populations in EAE. Having in mind that cucumber (Cucumis sativus) is a rich source of secondary metabolites such as polyphenols and cucurbitacins, in this study, for the first time, the effects of various cucumber extracts were investigated on encephalytogenic T lymphocytes, effector function of macrophages and antigen-presenting activities of dendritic cells (DC). The results show that cucumber leaf extract (CLE) expresses the most potent effect by inhibiting the production of IFN-γ and IL-17 in encephalytogenic T lymphocytes, through modulation of signaling pathways Nf-κB and p38 (MAPK). Additionally, CLE imposes an inhibitory effect on the effector functions of macrophages and antigen-presenting activity of DC in concentrations that do not show cytotoxicity in zebrafish (Danio rerio) in vivo. Also, CLE inhibits generation of encephalitogenic cells in vivo. Phytochemical analysis of CLE, characterized by mass spectrometry, confirmed the presence of 37 different compounds, among which cucurbitacins were the most abundant compounds. Hence, the immunomodulatory effects of cucurbitacin B and cucurbitacin E were also examined on the major immune cells involved in EAE pathogenesis. The obtained results confirm the effects of CLE, suggesting that cucurbitacins are, at least partially, responsible for its effects. The results of this doctoral dissertation indicate that the cucumber leaf extract and its major constituents cucurbitacins have anti-encephalitogenic effects in the EAE model, Moreover, they suggest the importance of additional research towards novel highly efficient CNS autoimmunity treatments.",
publisher = "Belgrade: University of Belgrade, Faculty of Biology",
journal = "University of Belgrade, Faculty of Biology",
title = "Uticaj različitih ekstrakata krastavca (Cucumis sativus L. cv. Chinese long) na encefalitogeni potencijal T limfocita pacova u eksperimentalnom autoimunskom encefalomijelitisu, Effects of different Cucumber extracts (Cucumis sativus L. cv. Chinese long) on the encephalitogenic pontential of T lymphocytes in experimental autoimmune encephalomyelitis",
pages = "1-141",
url = "https://hdl.handle.net/21.15107/rcub_ibiss_3104"
}
Jevtić, B.. (2018). Uticaj različitih ekstrakata krastavca (Cucumis sativus L. cv. Chinese long) na encefalitogeni potencijal T limfocita pacova u eksperimentalnom autoimunskom encefalomijelitisu. in University of Belgrade, Faculty of Biology
Belgrade: University of Belgrade, Faculty of Biology., 1-141.
https://hdl.handle.net/21.15107/rcub_ibiss_3104
Jevtić B. Uticaj različitih ekstrakata krastavca (Cucumis sativus L. cv. Chinese long) na encefalitogeni potencijal T limfocita pacova u eksperimentalnom autoimunskom encefalomijelitisu. in University of Belgrade, Faculty of Biology. 2018;:1-141.
https://hdl.handle.net/21.15107/rcub_ibiss_3104 .
Jevtić, Bojan, "Uticaj različitih ekstrakata krastavca (Cucumis sativus L. cv. Chinese long) na encefalitogeni potencijal T limfocita pacova u eksperimentalnom autoimunskom encefalomijelitisu" in University of Belgrade, Faculty of Biology (2018):1-141,
https://hdl.handle.net/21.15107/rcub_ibiss_3104 .

Pomegranate peel extract ameliorates autoimmunity in animal models of multiple sclerosis and type 1 diabetes

Stojanović, Ivana D.; Šavikin, Katarina; Nikolovski, Neda; Živković, Jelena; Saksida, Tamara; Momčilović, Miljana; Koprivica, Ivan; Vujičić, Milica; Stanisavljević, Suzana; Miljković, Đorđe; Menković, Nebojša

(2017)

TY  - JOUR
AU  - Stojanović, Ivana D.
AU  - Šavikin, Katarina
AU  - Nikolovski, Neda
AU  - Živković, Jelena
AU  - Saksida, Tamara
AU  - Momčilović, Miljana
AU  - Koprivica, Ivan
AU  - Vujičić, Milica
AU  - Stanisavljević, Suzana
AU  - Miljković, Đorđe
AU  - Menković, Nebojša
PY  - 2017
UR  - http://linkinghub.elsevier.com/retrieve/pii/S1756464617303353
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/2793
AB  - Pomegranate peel extract (PPE) was obtained by aqueous-ethanol extraction and was abundant in punicalin, punicalagin and ellagic acid. As these compounds are known to act against inflammation and oxidative stress in synergistic fashion, effects of PPE were tested in vitro on immune cells and in animal models of multiple sclerosis and type 1 diabetes (T1D). In vitro, PPE inhibited interleukin-17 (IL-17) production from gut-associated lymphoid tissue (GALT) cells. PPE also reduced production of IL-17 in activated T cells isolated from animals with experimental autoimmune encephalomyelitis (EAE). It efficiently down-regulated clinical symptoms of EAE in DA rats and of streptozotocin-induced T1D in C57BL/6 mice. The effect of PPE in T1D was mediated by inhibition of immune cell infiltration into pancreatic islets and through interference with IL-17 and IFN-γ production in GALT. Our results suggest that PPE has the potential to be used as phytopharmaceutical for certain autoimmune and chronic inflammatory disorders.
T2  - Journal of Functional Foods
T1  - Pomegranate peel extract ameliorates autoimmunity in animal models of multiple sclerosis and type 1 diabetes
VL  - 35
DO  - 10.1016/j.jff.2017.06.021
SP  - 522
EP  - 530
ER  - 
@article{
author = "Stojanović, Ivana D. and Šavikin, Katarina and Nikolovski, Neda and Živković, Jelena and Saksida, Tamara and Momčilović, Miljana and Koprivica, Ivan and Vujičić, Milica and Stanisavljević, Suzana and Miljković, Đorđe and Menković, Nebojša",
year = "2017",
abstract = "Pomegranate peel extract (PPE) was obtained by aqueous-ethanol extraction and was abundant in punicalin, punicalagin and ellagic acid. As these compounds are known to act against inflammation and oxidative stress in synergistic fashion, effects of PPE were tested in vitro on immune cells and in animal models of multiple sclerosis and type 1 diabetes (T1D). In vitro, PPE inhibited interleukin-17 (IL-17) production from gut-associated lymphoid tissue (GALT) cells. PPE also reduced production of IL-17 in activated T cells isolated from animals with experimental autoimmune encephalomyelitis (EAE). It efficiently down-regulated clinical symptoms of EAE in DA rats and of streptozotocin-induced T1D in C57BL/6 mice. The effect of PPE in T1D was mediated by inhibition of immune cell infiltration into pancreatic islets and through interference with IL-17 and IFN-γ production in GALT. Our results suggest that PPE has the potential to be used as phytopharmaceutical for certain autoimmune and chronic inflammatory disorders.",
journal = "Journal of Functional Foods",
title = "Pomegranate peel extract ameliorates autoimmunity in animal models of multiple sclerosis and type 1 diabetes",
volume = "35",
doi = "10.1016/j.jff.2017.06.021",
pages = "522-530"
}
Stojanović, I. D., Šavikin, K., Nikolovski, N., Živković, J., Saksida, T., Momčilović, M., Koprivica, I., Vujičić, M., Stanisavljević, S., Miljković, Đ.,& Menković, N.. (2017). Pomegranate peel extract ameliorates autoimmunity in animal models of multiple sclerosis and type 1 diabetes. in Journal of Functional Foods, 35, 522-530.
https://doi.org/10.1016/j.jff.2017.06.021
Stojanović ID, Šavikin K, Nikolovski N, Živković J, Saksida T, Momčilović M, Koprivica I, Vujičić M, Stanisavljević S, Miljković Đ, Menković N. Pomegranate peel extract ameliorates autoimmunity in animal models of multiple sclerosis and type 1 diabetes. in Journal of Functional Foods. 2017;35:522-530.
doi:10.1016/j.jff.2017.06.021 .
Stojanović, Ivana D., Šavikin, Katarina, Nikolovski, Neda, Živković, Jelena, Saksida, Tamara, Momčilović, Miljana, Koprivica, Ivan, Vujičić, Milica, Stanisavljević, Suzana, Miljković, Đorđe, Menković, Nebojša, "Pomegranate peel extract ameliorates autoimmunity in animal models of multiple sclerosis and type 1 diabetes" in Journal of Functional Foods, 35 (2017):522-530,
https://doi.org/10.1016/j.jff.2017.06.021 . .
6
44
25
46

Anti-encephalitogenic effects of cucumber leaf extract

Jevtić, Bojan; Nikolovski, Neda; Stanisavljević, Suzana; Gašić, Uroš; Mišić, Danijela; Despotović, Jovana; Samardžić, Jelena; Miljković, Đorđe; Timotijević, Gordana

(2017)

TY  - JOUR
AU  - Jevtić, Bojan
AU  - Nikolovski, Neda
AU  - Stanisavljević, Suzana
AU  - Gašić, Uroš
AU  - Mišić, Danijela
AU  - Despotović, Jovana
AU  - Samardžić, Jelena
AU  - Miljković, Đorđe
AU  - Timotijević, Gordana
PY  - 2017
UR  - http://linkinghub.elsevier.com/retrieve/pii/S1756464617304486
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/2832
AB  - Cucumber (Cucumis sativus) fruit has been used in cuisine worldwide, while its leaves are rich in immunomodulatory compounds. Cucumber leaf extract (CLE) was characterized by the predominance of triterpenoids cucurbitacins and significant levels of phenolics. Effects of CLE on CD4 + T helper (Th) cells and macrophages, as the major encephalitogenic cells in the autoimmunity of the central nervous system were investigated in our study. CLE potently inhibited production of major pathogenic Th cytokines: interferon-gamma and interleukin-17, as well as of nitric oxide and reactive oxygen species in macrophages. Antigen-presenting activity of macrophages and dendritic cells was also affected by CLE. The effects of CLE were co-incident with modulation of NFκB and p38 MAPK signaling. Concentrations of CLE used in vitro did not show toxic effects on zebrafish embryos. Moreover, CLE inhibited generation of encephalitogenic cells in vivo. These results demonstrate that CLE deserve further investigation on its anti-encephalitogenic therapeutic properties.
T2  - Journal of Functional Foods
T1  - Anti-encephalitogenic effects of cucumber leaf extract
VL  - 37
DO  - 10.1016/j.jff.2017.07.060
SP  - 249
EP  - 262
ER  - 
@article{
author = "Jevtić, Bojan and Nikolovski, Neda and Stanisavljević, Suzana and Gašić, Uroš and Mišić, Danijela and Despotović, Jovana and Samardžić, Jelena and Miljković, Đorđe and Timotijević, Gordana",
year = "2017",
abstract = "Cucumber (Cucumis sativus) fruit has been used in cuisine worldwide, while its leaves are rich in immunomodulatory compounds. Cucumber leaf extract (CLE) was characterized by the predominance of triterpenoids cucurbitacins and significant levels of phenolics. Effects of CLE on CD4 + T helper (Th) cells and macrophages, as the major encephalitogenic cells in the autoimmunity of the central nervous system were investigated in our study. CLE potently inhibited production of major pathogenic Th cytokines: interferon-gamma and interleukin-17, as well as of nitric oxide and reactive oxygen species in macrophages. Antigen-presenting activity of macrophages and dendritic cells was also affected by CLE. The effects of CLE were co-incident with modulation of NFκB and p38 MAPK signaling. Concentrations of CLE used in vitro did not show toxic effects on zebrafish embryos. Moreover, CLE inhibited generation of encephalitogenic cells in vivo. These results demonstrate that CLE deserve further investigation on its anti-encephalitogenic therapeutic properties.",
journal = "Journal of Functional Foods",
title = "Anti-encephalitogenic effects of cucumber leaf extract",
volume = "37",
doi = "10.1016/j.jff.2017.07.060",
pages = "249-262"
}
Jevtić, B., Nikolovski, N., Stanisavljević, S., Gašić, U., Mišić, D., Despotović, J., Samardžić, J., Miljković, Đ.,& Timotijević, G.. (2017). Anti-encephalitogenic effects of cucumber leaf extract. in Journal of Functional Foods, 37, 249-262.
https://doi.org/10.1016/j.jff.2017.07.060
Jevtić B, Nikolovski N, Stanisavljević S, Gašić U, Mišić D, Despotović J, Samardžić J, Miljković Đ, Timotijević G. Anti-encephalitogenic effects of cucumber leaf extract. in Journal of Functional Foods. 2017;37:249-262.
doi:10.1016/j.jff.2017.07.060 .
Jevtić, Bojan, Nikolovski, Neda, Stanisavljević, Suzana, Gašić, Uroš, Mišić, Danijela, Despotović, Jovana, Samardžić, Jelena, Miljković, Đorđe, Timotijević, Gordana, "Anti-encephalitogenic effects of cucumber leaf extract" in Journal of Functional Foods, 37 (2017):249-262,
https://doi.org/10.1016/j.jff.2017.07.060 . .
4
2
4

Strain-specific helper T cell profile in the gut-associated lymphoid tissue

Stanisavljević, Suzana; Nikolovski, Neda; Vujičić, Milica; Saksida, Tamara; Jevtić, Bojan; Milovanović, Boško; Momčilović, Miljana; Miljković, Đorđe; Stojanović, Ivana D.

(2017)

TY  - JOUR
AU  - Stanisavljević, Suzana
AU  - Nikolovski, Neda
AU  - Vujičić, Milica
AU  - Saksida, Tamara
AU  - Jevtić, Bojan
AU  - Milovanović, Boško
AU  - Momčilović, Miljana
AU  - Miljković, Đorđe
AU  - Stojanović, Ivana D.
PY  - 2017
UR  - http://linkinghub.elsevier.com/retrieve/pii/S0165247817301979
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/2854
AB  - C57BL/6, BALB/c and NOD mice are among the most frequently used strains in autoimmunity research. NOD mice spontaneously develop type 1 diabetes (T1D) and they are prone to induction of experimental autoimmune encephalomyelitis (EAE). Both diseases can be routinely induced in C57BL/6 mice, but not in BALB/c mice. Also, C57BL/6 mice are generally considered T helper (Th)1-biased and BALB/c Th2-biased mice. Having in mind increasingly appreciated role of gut associated lymphoid tissue (GALT) cells in autoimmunity, especially in relation to gut Th17 and regulatory T (Treg) cells, our aim was to determine if there are differences in proportion of CD4 + T cell populations in mesenteric lymph nodes and Peyer's p atches of these mouse strains. Lower proportion of Treg was observed in NOD PP, Th2 cells dominated in BALB/c mice in mesenteric lymph nodes (MLN) and Peyer's patches (PP), while Th1 cells prevailed in C57BL/6 MLN. Intradermal immunization of mice with complete Freund's adjuvant resulted in significant difference in Th cell distribution in GALT of NOD mice. Differences were less pronounced in C57BL/6 mice, while GALT of BALB/c mice was almost unresponsive to the immunization. The observed strain- and tissue-dependent changes in Treg proportion after the immunization was probably a consequence of different CCR2 or CCR6-related migration patterns and/or in situ Treg proliferation. In conclusion, NOD, a highly autoimmunity-prone mouse strain, exhibits more profound GALT-related immune response upon immunization compared to the strains that are less prone to autoimmunity.
T2  - Immunology Letters
T1  - Strain-specific helper T cell profile in the gut-associated lymphoid tissue
VL  - 190
DO  - 10.1016/j.imlet.2017.08.017
SP  - 282
EP  - 288
ER  - 
@article{
author = "Stanisavljević, Suzana and Nikolovski, Neda and Vujičić, Milica and Saksida, Tamara and Jevtić, Bojan and Milovanović, Boško and Momčilović, Miljana and Miljković, Đorđe and Stojanović, Ivana D.",
year = "2017",
abstract = "C57BL/6, BALB/c and NOD mice are among the most frequently used strains in autoimmunity research. NOD mice spontaneously develop type 1 diabetes (T1D) and they are prone to induction of experimental autoimmune encephalomyelitis (EAE). Both diseases can be routinely induced in C57BL/6 mice, but not in BALB/c mice. Also, C57BL/6 mice are generally considered T helper (Th)1-biased and BALB/c Th2-biased mice. Having in mind increasingly appreciated role of gut associated lymphoid tissue (GALT) cells in autoimmunity, especially in relation to gut Th17 and regulatory T (Treg) cells, our aim was to determine if there are differences in proportion of CD4 + T cell populations in mesenteric lymph nodes and Peyer's p atches of these mouse strains. Lower proportion of Treg was observed in NOD PP, Th2 cells dominated in BALB/c mice in mesenteric lymph nodes (MLN) and Peyer's patches (PP), while Th1 cells prevailed in C57BL/6 MLN. Intradermal immunization of mice with complete Freund's adjuvant resulted in significant difference in Th cell distribution in GALT of NOD mice. Differences were less pronounced in C57BL/6 mice, while GALT of BALB/c mice was almost unresponsive to the immunization. The observed strain- and tissue-dependent changes in Treg proportion after the immunization was probably a consequence of different CCR2 or CCR6-related migration patterns and/or in situ Treg proliferation. In conclusion, NOD, a highly autoimmunity-prone mouse strain, exhibits more profound GALT-related immune response upon immunization compared to the strains that are less prone to autoimmunity.",
journal = "Immunology Letters",
title = "Strain-specific helper T cell profile in the gut-associated lymphoid tissue",
volume = "190",
doi = "10.1016/j.imlet.2017.08.017",
pages = "282-288"
}
Stanisavljević, S., Nikolovski, N., Vujičić, M., Saksida, T., Jevtić, B., Milovanović, B., Momčilović, M., Miljković, Đ.,& Stojanović, I. D.. (2017). Strain-specific helper T cell profile in the gut-associated lymphoid tissue. in Immunology Letters, 190, 282-288.
https://doi.org/10.1016/j.imlet.2017.08.017
Stanisavljević S, Nikolovski N, Vujičić M, Saksida T, Jevtić B, Milovanović B, Momčilović M, Miljković Đ, Stojanović ID. Strain-specific helper T cell profile in the gut-associated lymphoid tissue. in Immunology Letters. 2017;190:282-288.
doi:10.1016/j.imlet.2017.08.017 .
Stanisavljević, Suzana, Nikolovski, Neda, Vujičić, Milica, Saksida, Tamara, Jevtić, Bojan, Milovanović, Boško, Momčilović, Miljana, Miljković, Đorđe, Stojanović, Ivana D., "Strain-specific helper T cell profile in the gut-associated lymphoid tissue" in Immunology Letters, 190 (2017):282-288,
https://doi.org/10.1016/j.imlet.2017.08.017 . .
13
9
11

Anti-encephalitogenic effects of ethyl pyruvate are reflected in the central nervous system and the gut.

Nikolovski, Neda; Stanisavljević, Suzana; Jevtić, Bojan; Momčilović, Miljana; Lavrnja, Irena; Miljković, Đorđe

(2017)

TY  - JOUR
AU  - Nikolovski, Neda
AU  - Stanisavljević, Suzana
AU  - Jevtić, Bojan
AU  - Momčilović, Miljana
AU  - Lavrnja, Irena
AU  - Miljković, Đorđe
PY  - 2017
UR  - http://linkinghub.elsevier.com/retrieve/pii/S0753332217331694
UR  - http://www.sciencedirect.com/science/article/pii/S0753332217331694
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/2864
AB  - Ethyl pyruvate is a redox analogue of dimethyl fumarate (Tecfidera), a drug for multiple sclerosis treatment. We have recently shown that ethyl pyruvate ameliorates experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. It affects encephalitogenic T cells and macrophages in vitro, as well as in lymph nodes draining the site of encephalitogenic immunization and within the central nervous system (CNS). Here, in vivo effects of ethyl pyruvate on EAE are thoroughly investigated in the CNS and within the gut associated lymphoid tissue. Ethyl pyruvate reduced infiltrates within the CNS and number of activated macrophages/microglia (ED1(+)/Iba1(+)) and proliferating astrocytes (GFAP(+)). Furthermore, it reduced expression of HMGB1 in activated macrophages/microglia. It also reduced number of activated T cells and antigen-presenting cells and expression of Th1/Th17-related molecules in mesenteric lymph nodes and Peyer's patches. These results contribute to our understanding of anti-encephalitogenic effects of ethyl pyruvate as they provide evidence of its effects within the CNS and imply that these effects are related to reduction of inflammatory immune response in gut associated lymphoid tissue.
T2  - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
T1  - Anti-encephalitogenic effects of ethyl pyruvate are reflected in the central nervous system and the gut.
VL  - 96
DO  - 10.1016/j.biopha.2017.09.110
SP  - 78
EP  - 85
ER  - 
@article{
author = "Nikolovski, Neda and Stanisavljević, Suzana and Jevtić, Bojan and Momčilović, Miljana and Lavrnja, Irena and Miljković, Đorđe",
year = "2017",
abstract = "Ethyl pyruvate is a redox analogue of dimethyl fumarate (Tecfidera), a drug for multiple sclerosis treatment. We have recently shown that ethyl pyruvate ameliorates experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. It affects encephalitogenic T cells and macrophages in vitro, as well as in lymph nodes draining the site of encephalitogenic immunization and within the central nervous system (CNS). Here, in vivo effects of ethyl pyruvate on EAE are thoroughly investigated in the CNS and within the gut associated lymphoid tissue. Ethyl pyruvate reduced infiltrates within the CNS and number of activated macrophages/microglia (ED1(+)/Iba1(+)) and proliferating astrocytes (GFAP(+)). Furthermore, it reduced expression of HMGB1 in activated macrophages/microglia. It also reduced number of activated T cells and antigen-presenting cells and expression of Th1/Th17-related molecules in mesenteric lymph nodes and Peyer's patches. These results contribute to our understanding of anti-encephalitogenic effects of ethyl pyruvate as they provide evidence of its effects within the CNS and imply that these effects are related to reduction of inflammatory immune response in gut associated lymphoid tissue.",
journal = "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie",
title = "Anti-encephalitogenic effects of ethyl pyruvate are reflected in the central nervous system and the gut.",
volume = "96",
doi = "10.1016/j.biopha.2017.09.110",
pages = "78-85"
}
Nikolovski, N., Stanisavljević, S., Jevtić, B., Momčilović, M., Lavrnja, I.,& Miljković, Đ.. (2017). Anti-encephalitogenic effects of ethyl pyruvate are reflected in the central nervous system and the gut.. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 96, 78-85.
https://doi.org/10.1016/j.biopha.2017.09.110
Nikolovski N, Stanisavljević S, Jevtić B, Momčilović M, Lavrnja I, Miljković Đ. Anti-encephalitogenic effects of ethyl pyruvate are reflected in the central nervous system and the gut.. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2017;96:78-85.
doi:10.1016/j.biopha.2017.09.110 .
Nikolovski, Neda, Stanisavljević, Suzana, Jevtić, Bojan, Momčilović, Miljana, Lavrnja, Irena, Miljković, Đorđe, "Anti-encephalitogenic effects of ethyl pyruvate are reflected in the central nervous system and the gut." in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 96 (2017):78-85,
https://doi.org/10.1016/j.biopha.2017.09.110 . .
1
24
14

Tenascin-C deficiency protects mice from experimental autoimmune encephalomyelitis

Momčilović, Miljana; Stamenković, Vera; Jovanović, Miloš; Anđus, Pavle R.; Jakovčevski, Igor; Schachner, Melitta; Miljković, Đorđe

(2017)

TY  - JOUR
AU  - Momčilović, Miljana
AU  - Stamenković, Vera
AU  - Jovanović, Miloš
AU  - Anđus, Pavle R.
AU  - Jakovčevski, Igor
AU  - Schachner, Melitta
AU  - Miljković, Đorđe
PY  - 2017
UR  - http://linkinghub.elsevier.com/retrieve/pii/S0165572816302077
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/2497
AB  - The extracellular matrix glycoprotein tenascin-C (TnC) has been increasingly appreciated as a molecule susceptibly reacting to abnormalities in the mammalian immune system. TnC expression is elevated in inflamed tissues outside the immune system, but also in lymphoid organs. It participates in the promotion of inflammatory responses. Here, the role of TnC in a paradigm of CNS autoimmunity was investigated. Experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis, was induced in mice deficient in TnC (TnC−/− mice). Amelioration of EAE was observed in these mice in comparison to their wild-type (TnC+/+) littermates. Since T helper (Th)1 and Th17 cells play a dominant role in the pathogenesis of EAE, these cells were investigated in addition to analyzing locomotor functions and pro-inflammatory cytokine levels. Smaller numbers of interferon-gamma-producing Th1 cells and reduced ability of Th17 cells to produce interleukin-17 were observed in spleens of TnC−/− mice challenged by immunization with the myelin associated glycoprotein (MOG) when compared to TnC+/+ mice. There was no difference in Th1 and Th17 responses in non-immunized TnC−/− and TnC+/+ mice, thus excluding generalized immunosuppression in TnC−/− mice. These results show that TnC is important for the pathogenesis of CNS autoimmunity and that its deficiency interferes with Th1 and Th17 encephalitogenic potentials.
T2  - Journal of Neuroimmunology
T1  - Tenascin-C deficiency protects mice from experimental autoimmune encephalomyelitis
VL  - 302
DO  - 10.1016/j.jneuroim.2016.12.001
SP  - 1
EP  - 6
ER  - 
@article{
author = "Momčilović, Miljana and Stamenković, Vera and Jovanović, Miloš and Anđus, Pavle R. and Jakovčevski, Igor and Schachner, Melitta and Miljković, Đorđe",
year = "2017",
abstract = "The extracellular matrix glycoprotein tenascin-C (TnC) has been increasingly appreciated as a molecule susceptibly reacting to abnormalities in the mammalian immune system. TnC expression is elevated in inflamed tissues outside the immune system, but also in lymphoid organs. It participates in the promotion of inflammatory responses. Here, the role of TnC in a paradigm of CNS autoimmunity was investigated. Experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis, was induced in mice deficient in TnC (TnC−/− mice). Amelioration of EAE was observed in these mice in comparison to their wild-type (TnC+/+) littermates. Since T helper (Th)1 and Th17 cells play a dominant role in the pathogenesis of EAE, these cells were investigated in addition to analyzing locomotor functions and pro-inflammatory cytokine levels. Smaller numbers of interferon-gamma-producing Th1 cells and reduced ability of Th17 cells to produce interleukin-17 were observed in spleens of TnC−/− mice challenged by immunization with the myelin associated glycoprotein (MOG) when compared to TnC+/+ mice. There was no difference in Th1 and Th17 responses in non-immunized TnC−/− and TnC+/+ mice, thus excluding generalized immunosuppression in TnC−/− mice. These results show that TnC is important for the pathogenesis of CNS autoimmunity and that its deficiency interferes with Th1 and Th17 encephalitogenic potentials.",
journal = "Journal of Neuroimmunology",
title = "Tenascin-C deficiency protects mice from experimental autoimmune encephalomyelitis",
volume = "302",
doi = "10.1016/j.jneuroim.2016.12.001",
pages = "1-6"
}
Momčilović, M., Stamenković, V., Jovanović, M., Anđus, P. R., Jakovčevski, I., Schachner, M.,& Miljković, Đ.. (2017). Tenascin-C deficiency protects mice from experimental autoimmune encephalomyelitis. in Journal of Neuroimmunology, 302, 1-6.
https://doi.org/10.1016/j.jneuroim.2016.12.001
Momčilović M, Stamenković V, Jovanović M, Anđus PR, Jakovčevski I, Schachner M, Miljković Đ. Tenascin-C deficiency protects mice from experimental autoimmune encephalomyelitis. in Journal of Neuroimmunology. 2017;302:1-6.
doi:10.1016/j.jneuroim.2016.12.001 .
Momčilović, Miljana, Stamenković, Vera, Jovanović, Miloš, Anđus, Pavle R., Jakovčevski, Igor, Schachner, Melitta, Miljković, Đorđe, "Tenascin-C deficiency protects mice from experimental autoimmune encephalomyelitis" in Journal of Neuroimmunology, 302 (2017):1-6,
https://doi.org/10.1016/j.jneuroim.2016.12.001 . .
1
25
14
25

Gut-associated lymphoid tissue, gut microbes and susceptibility to experimental autoimmune encephalomyelitis

Stanisavljević, Suzana; Lukić, Jovanka; Momčilović, Miljana; Miljković, Marija; Jevtić, Bojan; Kojić, Milan; Golić, Nataša; Mostarica Stojković, Marija; Miljković, Đorđe

(Wageningen Academic Publishers, 2016)

TY  - JOUR
AU  - Stanisavljević, Suzana
AU  - Lukić, Jovanka
AU  - Momčilović, Miljana
AU  - Miljković, Marija
AU  - Jevtić, Bojan
AU  - Kojić, Milan
AU  - Golić, Nataša
AU  - Mostarica Stojković, Marija
AU  - Miljković, Đorđe
PY  - 2016
UR  - http://radar.ibiss.bg.ac.rs/handle/123456789/6049
AB  - Gut microbiota and gut-associated lymphoid tissue have been increasingly appreciated as important players in pathogenesis of various autoimmune diseases, including multiple sclerosis. Experimental autoimmune encephalomyelitis (EAE) is an animal model of multiple sclerosis that can be induced with an injection of spinal cord homogenate emulsified in complete Freund's adjuvant in Dark Agouti (DA) rats, but not in Albino Oxford (AO) rats. In this study, mesenteric lymph nodes (MLN), Peyer's patches (PP) and gut microbiota were analysed in these two rat strains. There was higher proportion of CD4(+) T cells and regulatory T cells in non-immunised DA rats in comparison to AO rats. Also, DA rat MLN and PP cells were higher producers of pro-inflammatory cytokines interferon-γ and interleukin-17. Finally, microbial analyses showed that uncultivated species of Turicibacter and Atopostipes genus were exclusively present in AO rats, in faeces and intestinal tissue, respectively. Thus, it is clear that in comparison of an EAE-susceptible with an EAE-resistant strain of rats, various discrepancies at the level of gut associated lymphoid tissue, as well as at the level of gut microbiota can be observed. Future studies should determine if the differences have functional significance for EAE pathogenesis.
PB  - Wageningen Academic Publishers
T2  - Beneficial Microbes
T1  - Gut-associated lymphoid tissue, gut microbes and susceptibility to experimental autoimmune encephalomyelitis
IS  - 3
VL  - 7
DO  - 10.3920/BM2015.0159
SP  - 363
EP  - 373
ER  - 
@article{
author = "Stanisavljević, Suzana and Lukić, Jovanka and Momčilović, Miljana and Miljković, Marija and Jevtić, Bojan and Kojić, Milan and Golić, Nataša and Mostarica Stojković, Marija and Miljković, Đorđe",
year = "2016",
abstract = "Gut microbiota and gut-associated lymphoid tissue have been increasingly appreciated as important players in pathogenesis of various autoimmune diseases, including multiple sclerosis. Experimental autoimmune encephalomyelitis (EAE) is an animal model of multiple sclerosis that can be induced with an injection of spinal cord homogenate emulsified in complete Freund's adjuvant in Dark Agouti (DA) rats, but not in Albino Oxford (AO) rats. In this study, mesenteric lymph nodes (MLN), Peyer's patches (PP) and gut microbiota were analysed in these two rat strains. There was higher proportion of CD4(+) T cells and regulatory T cells in non-immunised DA rats in comparison to AO rats. Also, DA rat MLN and PP cells were higher producers of pro-inflammatory cytokines interferon-γ and interleukin-17. Finally, microbial analyses showed that uncultivated species of Turicibacter and Atopostipes genus were exclusively present in AO rats, in faeces and intestinal tissue, respectively. Thus, it is clear that in comparison of an EAE-susceptible with an EAE-resistant strain of rats, various discrepancies at the level of gut associated lymphoid tissue, as well as at the level of gut microbiota can be observed. Future studies should determine if the differences have functional significance for EAE pathogenesis.",
publisher = "Wageningen Academic Publishers",
journal = "Beneficial Microbes",
title = "Gut-associated lymphoid tissue, gut microbes and susceptibility to experimental autoimmune encephalomyelitis",
number = "3",
volume = "7",
doi = "10.3920/BM2015.0159",
pages = "363-373"
}
Stanisavljević, S., Lukić, J., Momčilović, M., Miljković, M., Jevtić, B., Kojić, M., Golić, N., Mostarica Stojković, M.,& Miljković, Đ.. (2016). Gut-associated lymphoid tissue, gut microbes and susceptibility to experimental autoimmune encephalomyelitis. in Beneficial Microbes
Wageningen Academic Publishers., 7(3), 363-373.
https://doi.org/10.3920/BM2015.0159
Stanisavljević S, Lukić J, Momčilović M, Miljković M, Jevtić B, Kojić M, Golić N, Mostarica Stojković M, Miljković Đ. Gut-associated lymphoid tissue, gut microbes and susceptibility to experimental autoimmune encephalomyelitis. in Beneficial Microbes. 2016;7(3):363-373.
doi:10.3920/BM2015.0159 .
Stanisavljević, Suzana, Lukić, Jovanka, Momčilović, Miljana, Miljković, Marija, Jevtić, Bojan, Kojić, Milan, Golić, Nataša, Mostarica Stojković, Marija, Miljković, Đorđe, "Gut-associated lymphoid tissue, gut microbes and susceptibility to experimental autoimmune encephalomyelitis" in Beneficial Microbes, 7, no. 3 (2016):363-373,
https://doi.org/10.3920/BM2015.0159 . .
1
30
15
29

Cucurbitacin E Potently Modulates the Activity of Encephalitogenic Cells

Jevtić, Bojan; Nikolovski, Neda; Stanisavljević, Suzana; Despotović, Jovana; Miljković, Đorđe; Timotijević, Gordana

(American Chemical Society, 2016)

TY  - JOUR
AU  - Jevtić, Bojan
AU  - Nikolovski, Neda
AU  - Stanisavljević, Suzana
AU  - Despotović, Jovana
AU  - Miljković, Đorđe
AU  - Timotijević, Gordana
PY  - 2016
UR  - http://radar.ibiss.bg.ac.rs/handle/123456789/6050
AB  - Cucurbitacin E (CucE) is a highly oxidized steroid consisting of a tetracyclic triterpene. It is a member of a Cucurbitacin family of biomolecules that are predominantly found in Cucurbitaceae plants. CucE has already been identified as a potent anti-inflammatory compound. Here, its effects on CD4(+) T helper (Th) cells and macrophages, as the major encephalitogenic cells in the autoimmunity of the central nervous system, were investigated. Production of major pathogenic Th cell cytokines: interferon-gamma and interleukin-17 were inhibited under the influence of CucE. The effects of CucE on CD4(+) T cells were mediated through the modulation of aryl hydrocarbon receptor, STAT3, NFκB, p38 MAPK, and miR-146 signaling. Further, production of nitric oxide and reactive oxygen species, as well as phagocytic ability, were inhibited in macrophages treated with CucE. These results imply that CucE possesses powerful antiencephalitogenic activity.
PB  - American Chemical Society
T2  - Journal of Agricultural and Food Chemistry
T1  - Cucurbitacin E Potently Modulates the Activity of Encephalitogenic Cells
IS  - 24
VL  - 64
DO  - 10.1021/acs.jafc.6b00951
SP  - 4900
EP  - 4907
ER  - 
@article{
author = "Jevtić, Bojan and Nikolovski, Neda and Stanisavljević, Suzana and Despotović, Jovana and Miljković, Đorđe and Timotijević, Gordana",
year = "2016",
abstract = "Cucurbitacin E (CucE) is a highly oxidized steroid consisting of a tetracyclic triterpene. It is a member of a Cucurbitacin family of biomolecules that are predominantly found in Cucurbitaceae plants. CucE has already been identified as a potent anti-inflammatory compound. Here, its effects on CD4(+) T helper (Th) cells and macrophages, as the major encephalitogenic cells in the autoimmunity of the central nervous system, were investigated. Production of major pathogenic Th cell cytokines: interferon-gamma and interleukin-17 were inhibited under the influence of CucE. The effects of CucE on CD4(+) T cells were mediated through the modulation of aryl hydrocarbon receptor, STAT3, NFκB, p38 MAPK, and miR-146 signaling. Further, production of nitric oxide and reactive oxygen species, as well as phagocytic ability, were inhibited in macrophages treated with CucE. These results imply that CucE possesses powerful antiencephalitogenic activity.",
publisher = "American Chemical Society",
journal = "Journal of Agricultural and Food Chemistry",
title = "Cucurbitacin E Potently Modulates the Activity of Encephalitogenic Cells",
number = "24",
volume = "64",
doi = "10.1021/acs.jafc.6b00951",
pages = "4900-4907"
}
Jevtić, B., Nikolovski, N., Stanisavljević, S., Despotović, J., Miljković, Đ.,& Timotijević, G.. (2016). Cucurbitacin E Potently Modulates the Activity of Encephalitogenic Cells. in Journal of Agricultural and Food Chemistry
American Chemical Society., 64(24), 4900-4907.
https://doi.org/10.1021/acs.jafc.6b00951
Jevtić B, Nikolovski N, Stanisavljević S, Despotović J, Miljković Đ, Timotijević G. Cucurbitacin E Potently Modulates the Activity of Encephalitogenic Cells. in Journal of Agricultural and Food Chemistry. 2016;64(24):4900-4907.
doi:10.1021/acs.jafc.6b00951 .
Jevtić, Bojan, Nikolovski, Neda, Stanisavljević, Suzana, Despotović, Jovana, Miljković, Đorđe, Timotijević, Gordana, "Cucurbitacin E Potently Modulates the Activity of Encephalitogenic Cells" in Journal of Agricultural and Food Chemistry, 64, no. 24 (2016):4900-4907,
https://doi.org/10.1021/acs.jafc.6b00951 . .
1
11
7
12

Correlation of Gut Microbiota Composition with Resistance to Experimental Autoimmune Encephalomyelitis in Rats

Stanisavljević, Suzana; Lukić, Jovanka; Soković, Svetlana; Mihajlović, Sanja; Mostarica Stojković, Marija; Miljković, Đorđe; Golić, Nataša

(2016)

TY  - JOUR
AU  - Stanisavljević, Suzana
AU  - Lukić, Jovanka
AU  - Soković, Svetlana
AU  - Mihajlović, Sanja
AU  - Mostarica Stojković, Marija
AU  - Miljković, Đorđe
AU  - Golić, Nataša
PY  - 2016
UR  - http://journal.frontiersin.org/article/10.3389/fmicb.2016.02005/full
UR  - https://www.scopus.com/record/display.uri?eid=2-s2.0-85008932586&origin=SingleRecordEmailAlert&dgcid=scalert_sc_search_email&txGid=4EB499CE54E80575D67A4CAC3995163A.wsnAw8kcdt7IPYLO0V48gA%3A1
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/2513
AB  - Multiple sclerosis is a chronic inflammatory disease of the central nervous system (CNS). It is widely accepted that autoimmune response against the antigens of the CNS is the essential pathogenic force in the disease. It has recently become increasingly appreciated that activated encephalitogenic cells tend to migrate toward gut associated lymphoid tissues (GALTs) and that interrupted balance between regulatory and inflammatory immunity within the GALT might have decisive role in the initiation and propagation of the CNS autoimmunity. Gut microbiota composition and function has the major impact on the balance in the GALT. Thus, our aim was to perform analyses of gut microbiota in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. Albino Oxford (AO) rats that are highly resistant to EAE induction and Dark Agouti (DA) rats that develop EAE after mild immunization were compared for gut microbiota composition in different phases after EAE induction. Microbial analyses of the genus Lactobacillus and related lactic acid bacteria showed higher diversity of Lactobacillus spp. in EAE-resistant AO rats, while some members of Firmicutes and Proteobacteria (Undibacterium oligocarboniphilum) were detected only in feces of DA rats at the peak of the disease (between 13 and 16 days after induction). Interestingly, in contrast to our previous study where Turicibacter sp. was found exclusively in non-immunized AO, but not in DA rats, in this study it was detected in DA rats that remained healthy 16 days after induction, as well as in four of 12 DA rats at the peak of the disease. Similar observation was obtained for the members of Lachnospiraceae. Further, production of a typical regulatory cytokine interleukin-10 was compared in GALT cells of AO and DA rats, and higher production was observed in DA rats. Our data contribute to the idea that gut microbiota and GALT considerably influence multiple sclerosis pathogenesis.
T2  - Frontiers in Microbiology
T1  - Correlation of Gut Microbiota Composition with Resistance to Experimental Autoimmune Encephalomyelitis in Rats
VL  - 7
DO  - 10.3389/fmicb.2016.02005
SP  - 2005
EP  - 2005
ER  - 
@article{
author = "Stanisavljević, Suzana and Lukić, Jovanka and Soković, Svetlana and Mihajlović, Sanja and Mostarica Stojković, Marija and Miljković, Đorđe and Golić, Nataša",
year = "2016",
abstract = "Multiple sclerosis is a chronic inflammatory disease of the central nervous system (CNS). It is widely accepted that autoimmune response against the antigens of the CNS is the essential pathogenic force in the disease. It has recently become increasingly appreciated that activated encephalitogenic cells tend to migrate toward gut associated lymphoid tissues (GALTs) and that interrupted balance between regulatory and inflammatory immunity within the GALT might have decisive role in the initiation and propagation of the CNS autoimmunity. Gut microbiota composition and function has the major impact on the balance in the GALT. Thus, our aim was to perform analyses of gut microbiota in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. Albino Oxford (AO) rats that are highly resistant to EAE induction and Dark Agouti (DA) rats that develop EAE after mild immunization were compared for gut microbiota composition in different phases after EAE induction. Microbial analyses of the genus Lactobacillus and related lactic acid bacteria showed higher diversity of Lactobacillus spp. in EAE-resistant AO rats, while some members of Firmicutes and Proteobacteria (Undibacterium oligocarboniphilum) were detected only in feces of DA rats at the peak of the disease (between 13 and 16 days after induction). Interestingly, in contrast to our previous study where Turicibacter sp. was found exclusively in non-immunized AO, but not in DA rats, in this study it was detected in DA rats that remained healthy 16 days after induction, as well as in four of 12 DA rats at the peak of the disease. Similar observation was obtained for the members of Lachnospiraceae. Further, production of a typical regulatory cytokine interleukin-10 was compared in GALT cells of AO and DA rats, and higher production was observed in DA rats. Our data contribute to the idea that gut microbiota and GALT considerably influence multiple sclerosis pathogenesis.",
journal = "Frontiers in Microbiology",
title = "Correlation of Gut Microbiota Composition with Resistance to Experimental Autoimmune Encephalomyelitis in Rats",
volume = "7",
doi = "10.3389/fmicb.2016.02005",
pages = "2005-2005"
}
Stanisavljević, S., Lukić, J., Soković, S., Mihajlović, S., Mostarica Stojković, M., Miljković, Đ.,& Golić, N.. (2016). Correlation of Gut Microbiota Composition with Resistance to Experimental Autoimmune Encephalomyelitis in Rats. in Frontiers in Microbiology, 7, 2005-2005.
https://doi.org/10.3389/fmicb.2016.02005
Stanisavljević S, Lukić J, Soković S, Mihajlović S, Mostarica Stojković M, Miljković Đ, Golić N. Correlation of Gut Microbiota Composition with Resistance to Experimental Autoimmune Encephalomyelitis in Rats. in Frontiers in Microbiology. 2016;7:2005-2005.
doi:10.3389/fmicb.2016.02005 .
Stanisavljević, Suzana, Lukić, Jovanka, Soković, Svetlana, Mihajlović, Sanja, Mostarica Stojković, Marija, Miljković, Đorđe, Golić, Nataša, "Correlation of Gut Microbiota Composition with Resistance to Experimental Autoimmune Encephalomyelitis in Rats" in Frontiers in Microbiology, 7 (2016):2005-2005,
https://doi.org/10.3389/fmicb.2016.02005 . .
14
36
24
35

Cell death of ED1+ cells in the central nervous system of Dark Agouti rats at the peak of experimental autoimmune encephalitis

Nikolovski, Neda; Lavrnja, Irena; Wendrich, Katrin; Momčilović, Miljana; Paquet-Durand, François; Trifunović, Dragana; Miljković, Đorđe

(Belgrade: Immunological Society of Serbia, 2015)

TY  - CONF
AU  - Nikolovski, Neda
AU  - Lavrnja, Irena
AU  - Wendrich, Katrin
AU  - Momčilović, Miljana
AU  - Paquet-Durand, François
AU  - Trifunović, Dragana
AU  - Miljković, Đorđe
PY  - 2015
UR  - http://radar.ibiss.bg.ac.rs/handle/123456789/6061
AB  - Infiltration of macrophages into the central nervous system (CNS), as well
as activation of microglia is a hallmark of multiple sclerosis and its animal
model - experimental autoimmune encephalomyelitis (EAE). Cell death in
EAE has been demonstrated as an essential mechanism in the local
regulation of the inflammatory reaction, but also as one of the major factors
contributing to the destruction of the CNS tissue. Here, cell death of ED1+
cells (macrophages/microglia) in the spinal cord of EAE rats was
investigated. Cell death in general was assessed using the TUNEL assay,
while cleaved caspase-3 immunostaining was employed as the marker of
“classical” apoptosis. Dark Agouti (DA) rats were immunized with spinal
cord homogenate emulsified in complete Freund's adjuvant. Infiltrates of
immune cells were detected both in white matter (WM) and grey matter
(GM) of spinal cords in DA rats at the peak of EAE. ED1+, TUNEL+ and
caspase-3+ cells were detected within, but also outside the infiltrates. While
there were no differences in the proportion of TUNEL+ ED1+ cells between
infiltrates and non-infiltrated areas in WM, there were more ED1+TUNEL+
cells in GM in infiltrates than in non–infiltrated areas. A similar distribution
was observed for ED1+caspase-3+ cells. The observed discrepancy in
distribution of dead ED1+ cells in infiltrates and non-infiltrated areas in GM
and WM of spinal cord indicated that differential spatial regulation of
macrophage/microglia cell death occurred in DA rats. These findings
contribute to the understanding of pathogenesis of EAE in DA rats. It also
opens new perspectives for a research aiming at more efficient treatment of
multiple sclerosis.
PB  - Belgrade: Immunological Society of Serbia
C3  - 3rd Belgrade EFIS symposium on Immunoregulation: Immunity, Infection, Autoimmunity and Aging; 2015 May 24-27; Arandjelovac, Serbia
T1  - Cell death of ED1+ cells in the central nervous system of Dark Agouti rats at the peak of experimental autoimmune encephalitis
SP  - 67
UR  - https://hdl.handle.net/21.15107/rcub_ibiss_6061
ER  - 
@conference{
author = "Nikolovski, Neda and Lavrnja, Irena and Wendrich, Katrin and Momčilović, Miljana and Paquet-Durand, François and Trifunović, Dragana and Miljković, Đorđe",
year = "2015",
abstract = "Infiltration of macrophages into the central nervous system (CNS), as well
as activation of microglia is a hallmark of multiple sclerosis and its animal
model - experimental autoimmune encephalomyelitis (EAE). Cell death in
EAE has been demonstrated as an essential mechanism in the local
regulation of the inflammatory reaction, but also as one of the major factors
contributing to the destruction of the CNS tissue. Here, cell death of ED1+
cells (macrophages/microglia) in the spinal cord of EAE rats was
investigated. Cell death in general was assessed using the TUNEL assay,
while cleaved caspase-3 immunostaining was employed as the marker of
“classical” apoptosis. Dark Agouti (DA) rats were immunized with spinal
cord homogenate emulsified in complete Freund's adjuvant. Infiltrates of
immune cells were detected both in white matter (WM) and grey matter
(GM) of spinal cords in DA rats at the peak of EAE. ED1+, TUNEL+ and
caspase-3+ cells were detected within, but also outside the infiltrates. While
there were no differences in the proportion of TUNEL+ ED1+ cells between
infiltrates and non-infiltrated areas in WM, there were more ED1+TUNEL+
cells in GM in infiltrates than in non–infiltrated areas. A similar distribution
was observed for ED1+caspase-3+ cells. The observed discrepancy in
distribution of dead ED1+ cells in infiltrates and non-infiltrated areas in GM
and WM of spinal cord indicated that differential spatial regulation of
macrophage/microglia cell death occurred in DA rats. These findings
contribute to the understanding of pathogenesis of EAE in DA rats. It also
opens new perspectives for a research aiming at more efficient treatment of
multiple sclerosis.",
publisher = "Belgrade: Immunological Society of Serbia",
journal = "3rd Belgrade EFIS symposium on Immunoregulation: Immunity, Infection, Autoimmunity and Aging; 2015 May 24-27; Arandjelovac, Serbia",
title = "Cell death of ED1+ cells in the central nervous system of Dark Agouti rats at the peak of experimental autoimmune encephalitis",
pages = "67",
url = "https://hdl.handle.net/21.15107/rcub_ibiss_6061"
}
Nikolovski, N., Lavrnja, I., Wendrich, K., Momčilović, M., Paquet-Durand, F., Trifunović, D.,& Miljković, Đ.. (2015). Cell death of ED1+ cells in the central nervous system of Dark Agouti rats at the peak of experimental autoimmune encephalitis. in 3rd Belgrade EFIS symposium on Immunoregulation: Immunity, Infection, Autoimmunity and Aging; 2015 May 24-27; Arandjelovac, Serbia
Belgrade: Immunological Society of Serbia., 67.
https://hdl.handle.net/21.15107/rcub_ibiss_6061
Nikolovski N, Lavrnja I, Wendrich K, Momčilović M, Paquet-Durand F, Trifunović D, Miljković Đ. Cell death of ED1+ cells in the central nervous system of Dark Agouti rats at the peak of experimental autoimmune encephalitis. in 3rd Belgrade EFIS symposium on Immunoregulation: Immunity, Infection, Autoimmunity and Aging; 2015 May 24-27; Arandjelovac, Serbia. 2015;:67.
https://hdl.handle.net/21.15107/rcub_ibiss_6061 .
Nikolovski, Neda, Lavrnja, Irena, Wendrich, Katrin, Momčilović, Miljana, Paquet-Durand, François, Trifunović, Dragana, Miljković, Đorđe, "Cell death of ED1+ cells in the central nervous system of Dark Agouti rats at the peak of experimental autoimmune encephalitis" in 3rd Belgrade EFIS symposium on Immunoregulation: Immunity, Infection, Autoimmunity and Aging; 2015 May 24-27; Arandjelovac, Serbia (2015):67,
https://hdl.handle.net/21.15107/rcub_ibiss_6061 .

Activity, but not mRNA expression of gelatinases correlates with susceptibility to experimental autoimmune encephalomyelitis

Petković, Filip; Živanović, Jasmina; Blaževski, Jana; Timotijević, G.; Momčilović, Miljana; Stanojević, Ž.; Stamenković, V.; Milošević, Verica; Stojković, M. Mostarica; Miljković, Đorđe

(2015)

TY  - JOUR
AU  - Petković, Filip
AU  - Živanović, Jasmina
AU  - Blaževski, Jana
AU  - Timotijević, G.
AU  - Momčilović, Miljana
AU  - Stanojević, Ž.
AU  - Stamenković, V.
AU  - Milošević, Verica
AU  - Stojković, M. Mostarica
AU  - Miljković, Đorđe
PY  - 2015
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/1968
AB  - Experimental autoimmune encephalomyelitis (EAE) is a model of multiple
   sclerosis (MS), inflammatory, demyelinating and neurodegenerative
   disease of the central nervous system (CNS). Clinically manifested EAE
   can be induced in Dark Agouti (DA) rats, but not in Albino Oxford (AO)
   rats by immunization with spinal cord homogenate (SCH) and complete
   Freund's adjuvant (CFA). Matrix metalloproteinases (MMP) play important
   roles in various steps of MS and EAE pathogenesis. Expression of
   gelatinases MMP2 and MMP9, their activator MMP14 and their inhibitor
   tissue inhibitor of MMP (TIMP) 1 in the CNS of AO and DA rats immunized
   with SCH + CFA was determined. Expression of mRNA for MMP2, MMP9 and
   MMP14 was higher and expression of TIMP1 mRNA was lower in AO rats.
   However, gelatinase activity in spinal cords was higher in samples
   obtained from DA rats. Further, while there was no strain difference in
   MMP2 and MMP9 mRNA expression in lymph nodes of the immunized rats,
   gelatinase activity was higher in DA rats. This activity was reduced by
   antiinflammatory cytokines interleukin (IL)-10 and IL-4. Interestingly,
   gelatinase activity was detected in the nuclei of cells within the CNS,
   but not of those in lymph nodes. Our results imply that
   posttranscriptional regulation of MMP2 and MMP9 expression and/or
   function determines low gelatinase activity within the CNS and in immune
   cells of EAE-resistant AO rats. (C) 2015 IBRO. Published by Elsevier
   Ltd. All rights reserved.
T2  - Neuroscience
T1  - Activity, but not mRNA expression of gelatinases correlates with susceptibility to experimental autoimmune encephalomyelitis
VL  - 292
DO  - 10.1016/j.neuroscience.2015.02.015
SP  - 1
EP  - 12
ER  - 
@article{
author = "Petković, Filip and Živanović, Jasmina and Blaževski, Jana and Timotijević, G. and Momčilović, Miljana and Stanojević, Ž. and Stamenković, V. and Milošević, Verica and Stojković, M. Mostarica and Miljković, Đorđe",
year = "2015",
abstract = "Experimental autoimmune encephalomyelitis (EAE) is a model of multiple
   sclerosis (MS), inflammatory, demyelinating and neurodegenerative
   disease of the central nervous system (CNS). Clinically manifested EAE
   can be induced in Dark Agouti (DA) rats, but not in Albino Oxford (AO)
   rats by immunization with spinal cord homogenate (SCH) and complete
   Freund's adjuvant (CFA). Matrix metalloproteinases (MMP) play important
   roles in various steps of MS and EAE pathogenesis. Expression of
   gelatinases MMP2 and MMP9, their activator MMP14 and their inhibitor
   tissue inhibitor of MMP (TIMP) 1 in the CNS of AO and DA rats immunized
   with SCH + CFA was determined. Expression of mRNA for MMP2, MMP9 and
   MMP14 was higher and expression of TIMP1 mRNA was lower in AO rats.
   However, gelatinase activity in spinal cords was higher in samples
   obtained from DA rats. Further, while there was no strain difference in
   MMP2 and MMP9 mRNA expression in lymph nodes of the immunized rats,
   gelatinase activity was higher in DA rats. This activity was reduced by
   antiinflammatory cytokines interleukin (IL)-10 and IL-4. Interestingly,
   gelatinase activity was detected in the nuclei of cells within the CNS,
   but not of those in lymph nodes. Our results imply that
   posttranscriptional regulation of MMP2 and MMP9 expression and/or
   function determines low gelatinase activity within the CNS and in immune
   cells of EAE-resistant AO rats. (C) 2015 IBRO. Published by Elsevier
   Ltd. All rights reserved.",
journal = "Neuroscience",
title = "Activity, but not mRNA expression of gelatinases correlates with susceptibility to experimental autoimmune encephalomyelitis",
volume = "292",
doi = "10.1016/j.neuroscience.2015.02.015",
pages = "1-12"
}
Petković, F., Živanović, J., Blaževski, J., Timotijević, G., Momčilović, M., Stanojević, Ž., Stamenković, V., Milošević, V., Stojković, M. M.,& Miljković, Đ.. (2015). Activity, but not mRNA expression of gelatinases correlates with susceptibility to experimental autoimmune encephalomyelitis. in Neuroscience, 292, 1-12.
https://doi.org/10.1016/j.neuroscience.2015.02.015
Petković F, Živanović J, Blaževski J, Timotijević G, Momčilović M, Stanojević Ž, Stamenković V, Milošević V, Stojković MM, Miljković Đ. Activity, but not mRNA expression of gelatinases correlates with susceptibility to experimental autoimmune encephalomyelitis. in Neuroscience. 2015;292:1-12.
doi:10.1016/j.neuroscience.2015.02.015 .
Petković, Filip, Živanović, Jasmina, Blaževski, Jana, Timotijević, G., Momčilović, Miljana, Stanojević, Ž., Stamenković, V., Milošević, Verica, Stojković, M. Mostarica, Miljković, Đorđe, "Activity, but not mRNA expression of gelatinases correlates with susceptibility to experimental autoimmune encephalomyelitis" in Neuroscience, 292 (2015):1-12,
https://doi.org/10.1016/j.neuroscience.2015.02.015 . .
2
2
2

Ekspresija, produkcija i moguća uloga interleukina 10 i faktora nekroze tumora tokom eksperimentalnog autoimunskog encefalomijelitisa u pacova sojeva AO i DA

Blaževski, Jana V.

(Belgrade: University of Belgrade, Faculty of Biology, 2014)

TY  - THES
AU  - Blaževski, Jana V.
PY  - 2014
UR  - http://eteze.bg.ac.rs/application/showtheses?thesesId=3075
UR  - https://fedorabg.bg.ac.rs/fedora/get/o:11341/bdef:Content/download
UR  - http://vbs.rs/scripts/cobiss?command=DISPLAY&base=70036&RID=1024770482
UR  - http://nardus.mpn.gov.rs/123456789/5673
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/2587
AB  - Multipla skleroza (MS) je hronična inflamatorna i neurodegenerativna bolest centralnognervnog sistema (CNS) sa autoimunskom patogenezom. Najčešće pogađa populacijuizmeđu 20-40 godina, češća je kod žena nego kod muškaraca, kao i u Evropi i SevernojAmerici u odnosu na druge delove sveta. Iako još uvek nije jasno definisan uzroknastanka ove bolesti, smatra se da su u njenoj osnovi kompleksne interakcije izmeđurazličitih gena i faktora sredine.Eksperimentalni autoimunski encefalomijelitis (EAE) je najkorišćeniji animalni modelMS-a. Indukuje se najčešće u glodarima i to imunizacijom, korišćenjem homogenatatkiva CNS-a, mijelina ili nekih od proteina mijelina koji se mešaju sa adjuvansom.Nakon imunizacije, CD4+ T-ćelije specifične za antigen CNS-a proliferišu idiferenciraju se u drenirajućem limfnom čvoru, nakon čega dolazi do njihove migracijei širenja po celom organizmu. Deo ćelija specifičnih za antigene nervnog sistema odlaziu CNS, prolazi kroz krvno-moždanu barijeru i u perivaskularnom prostoru prepoznajeantigen za koji je specifičan. Nakon susreta sa antigenom T-ćelije bivaju reaktivirane,počinju da produkuju odgovarajuće citokine, aktiviraju lokalne ćelije i dalje privlačeinflamatorne ćelije u CNS. Na ovaj način nastaje inflamatorna reakcija koja zaposledicu ima uništavanje mijelinskog omotača, a u određenim slučajevima i aksonadovodeći tako do neurodegeneracije.Citokini predstavljaju bitne medijatore svakog inflamatornog procesa. IL-10 je antiinflamatornicitokin sa osnovnom ulogom u zaštiti tkiva i ograničavanju preteranoginflamatornog odgovora. Sa druge strane, TNF je predstavniik pro-inflamatorne grupecitokina koji ima ključnu ulogu medijatora akutne i hronične sistemske inflamatornereakcije. Oba citokina su dosta proučavana u EAE modelu, gde se IL-10 u najširemsmislu smatra protektivnim, dok se TNF uglavnom smatra štetnim i odgovornim zapojačavanje inflamatorne rekcije...
AB  - Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of thecentral nervous system (CNS) with a proposed autoimmune pathogenesis. It mainlyaffects population between 20-40 years of age, more often women in comparison to menAlso, it is more often in Europe and north America comparing to other parts of theworld.. The cause of this disease is still not well defined, but it is thought to be complexinteraction between genes and different environmental factors.Experimental autoimmune encephalomyelitis (EAE) is the most commonly used MSanimal model. It is mostly induced in rodents by using spinal cord homogenate, myelinor some of the myelin’s proteins and mixing them with adjuvants. After theimmunization antigen specific CD4+ T cells proliferate and differentiate in draininglymph nodes after which they migrate and spread all around the body. One part of theantigen specific cells goes to CNS, crosses blood-brain barrier and enters theperivascular space where it recognizes antigens which they are specific for. Afterencountering the antigens T cells are reactivated and they start producing cytokines,activate local cells and attract other inflammatory cells in to the CNS. This is howinflammatory reaction begins leading to distraction of myelin sheet or even axons insome cases, finally causing neurodegeneration.Cytokines are important mediators of every inflammatory process. IL-10 is an antiinflammatorycytokine with a primary role in tissue protection and restriction ofinflammatory response. On the other hand, TNF is a classical pro-inflammatorycytokine which mediates acute and chronic systemic inflammatory reaction. The role ofboth these cytokines has been well studied in EAE model, where IL-10 is considered tobe protective while TNF is mostly thought of as deleterious and responsible forincreasing the inflammatory reaction...
PB  - Belgrade: University of Belgrade, Faculty of Biology
T2  - University of Belgrade, Faculty of Biology
T1  - Ekspresija, produkcija i moguća uloga interleukina 10 i faktora nekroze tumora tokom eksperimentalnog autoimunskog encefalomijelitisa u pacova sojeva AO i DA
T1  - Experession, production and possible role of interleukin 10 and tumor necrosis factor during experimental autoimmune encephalomyelitis in AO and DA rats
SP  - 1
EP  - 141
UR  - https://hdl.handle.net/21.15107/rcub_nardus_5673
ER  - 
@phdthesis{
author = "Blaževski, Jana V.",
year = "2014",
abstract = "Multipla skleroza (MS) je hronična inflamatorna i neurodegenerativna bolest centralnognervnog sistema (CNS) sa autoimunskom patogenezom. Najčešće pogađa populacijuizmeđu 20-40 godina, češća je kod žena nego kod muškaraca, kao i u Evropi i SevernojAmerici u odnosu na druge delove sveta. Iako još uvek nije jasno definisan uzroknastanka ove bolesti, smatra se da su u njenoj osnovi kompleksne interakcije izmeđurazličitih gena i faktora sredine.Eksperimentalni autoimunski encefalomijelitis (EAE) je najkorišćeniji animalni modelMS-a. Indukuje se najčešće u glodarima i to imunizacijom, korišćenjem homogenatatkiva CNS-a, mijelina ili nekih od proteina mijelina koji se mešaju sa adjuvansom.Nakon imunizacije, CD4+ T-ćelije specifične za antigen CNS-a proliferišu idiferenciraju se u drenirajućem limfnom čvoru, nakon čega dolazi do njihove migracijei širenja po celom organizmu. Deo ćelija specifičnih za antigene nervnog sistema odlaziu CNS, prolazi kroz krvno-moždanu barijeru i u perivaskularnom prostoru prepoznajeantigen za koji je specifičan. Nakon susreta sa antigenom T-ćelije bivaju reaktivirane,počinju da produkuju odgovarajuće citokine, aktiviraju lokalne ćelije i dalje privlačeinflamatorne ćelije u CNS. Na ovaj način nastaje inflamatorna reakcija koja zaposledicu ima uništavanje mijelinskog omotača, a u određenim slučajevima i aksonadovodeći tako do neurodegeneracije.Citokini predstavljaju bitne medijatore svakog inflamatornog procesa. IL-10 je antiinflamatornicitokin sa osnovnom ulogom u zaštiti tkiva i ograničavanju preteranoginflamatornog odgovora. Sa druge strane, TNF je predstavniik pro-inflamatorne grupecitokina koji ima ključnu ulogu medijatora akutne i hronične sistemske inflamatornereakcije. Oba citokina su dosta proučavana u EAE modelu, gde se IL-10 u najširemsmislu smatra protektivnim, dok se TNF uglavnom smatra štetnim i odgovornim zapojačavanje inflamatorne rekcije..., Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of thecentral nervous system (CNS) with a proposed autoimmune pathogenesis. It mainlyaffects population between 20-40 years of age, more often women in comparison to menAlso, it is more often in Europe and north America comparing to other parts of theworld.. The cause of this disease is still not well defined, but it is thought to be complexinteraction between genes and different environmental factors.Experimental autoimmune encephalomyelitis (EAE) is the most commonly used MSanimal model. It is mostly induced in rodents by using spinal cord homogenate, myelinor some of the myelin’s proteins and mixing them with adjuvants. After theimmunization antigen specific CD4+ T cells proliferate and differentiate in draininglymph nodes after which they migrate and spread all around the body. One part of theantigen specific cells goes to CNS, crosses blood-brain barrier and enters theperivascular space where it recognizes antigens which they are specific for. Afterencountering the antigens T cells are reactivated and they start producing cytokines,activate local cells and attract other inflammatory cells in to the CNS. This is howinflammatory reaction begins leading to distraction of myelin sheet or even axons insome cases, finally causing neurodegeneration.Cytokines are important mediators of every inflammatory process. IL-10 is an antiinflammatorycytokine with a primary role in tissue protection and restriction ofinflammatory response. On the other hand, TNF is a classical pro-inflammatorycytokine which mediates acute and chronic systemic inflammatory reaction. The role ofboth these cytokines has been well studied in EAE model, where IL-10 is considered tobe protective while TNF is mostly thought of as deleterious and responsible forincreasing the inflammatory reaction...",
publisher = "Belgrade: University of Belgrade, Faculty of Biology",
journal = "University of Belgrade, Faculty of Biology",
title = "Ekspresija, produkcija i moguća uloga interleukina 10 i faktora nekroze tumora tokom eksperimentalnog autoimunskog encefalomijelitisa u pacova sojeva AO i DA, Experession, production and possible role of interleukin 10 and tumor necrosis factor during experimental autoimmune encephalomyelitis in AO and DA rats",
pages = "1-141",
url = "https://hdl.handle.net/21.15107/rcub_nardus_5673"
}
Blaževski, J. V.. (2014). Ekspresija, produkcija i moguća uloga interleukina 10 i faktora nekroze tumora tokom eksperimentalnog autoimunskog encefalomijelitisa u pacova sojeva AO i DA. in University of Belgrade, Faculty of Biology
Belgrade: University of Belgrade, Faculty of Biology., 1-141.
https://hdl.handle.net/21.15107/rcub_nardus_5673
Blaževski JV. Ekspresija, produkcija i moguća uloga interleukina 10 i faktora nekroze tumora tokom eksperimentalnog autoimunskog encefalomijelitisa u pacova sojeva AO i DA. in University of Belgrade, Faculty of Biology. 2014;:1-141.
https://hdl.handle.net/21.15107/rcub_nardus_5673 .
Blaževski, Jana V., "Ekspresija, produkcija i moguća uloga interleukina 10 i faktora nekroze tumora tokom eksperimentalnog autoimunskog encefalomijelitisa u pacova sojeva AO i DA" in University of Belgrade, Faculty of Biology (2014):1-141,
https://hdl.handle.net/21.15107/rcub_nardus_5673 .

Multiple Sclerosis: Molecular Mechanisms and Therapeutic Opportunities

Miljković, Đorđe; Spasojević, Ivan B

(New Rochelle: Mary Ann Liebert, Inc., 2013)

TY  - JOUR
AU  - Miljković, Đorđe
AU  - Spasojević, Ivan B
PY  - 2013
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/937
AB  - The pathophysiology of multiple sclerosis (MS) involves several components: redox, inflammatory/autoimmune, vascular, and neurodegenerative. All of them are supported by the intertwined lines of evidence, and none of them should be written off. However, the exact mechanisms of MS initiation, its development, and progression are still elusive, despite the impressive pace by which the data on MS are accumulating. In this review, we will try to integrate the current facts and concepts, focusing on the role of redox changes and various reactive species in MS. Knowing the schedule of initial changes in pathogenic factors and the key turning points, as well as understanding the redox processes involved in MS pathogenesis is the way to enable MS prevention, early treatment, and the development of therapies that target specific pathophysiological components of the heterogeneous mechanisms of MS, which could alleviate the symptoms and hopefully stop MS. Pertinent to this, we will outline (i) redox processes involved in MS initiation; (ii) the role of reactive species in inflammation; (iii) prooxidative changes responsible for neurodegeneration; and (iv) the potential of antioxidative therapy. Antioxid. Redox Signal. 19, 2286-2334.
PB  - New Rochelle: Mary Ann Liebert, Inc.
T2  - Antioxidants & Redox Signaling
T1  - Multiple Sclerosis: Molecular Mechanisms and Therapeutic Opportunities
IS  - 18
VL  - 19
DO  - 10.1089/ars.2012.5068
SP  - 2286
EP  - 2334
UR  - https://hdl.handle.net/21.15107/rcub_ibiss_937
ER  - 
@article{
author = "Miljković, Đorđe and Spasojević, Ivan B",
year = "2013",
abstract = "The pathophysiology of multiple sclerosis (MS) involves several components: redox, inflammatory/autoimmune, vascular, and neurodegenerative. All of them are supported by the intertwined lines of evidence, and none of them should be written off. However, the exact mechanisms of MS initiation, its development, and progression are still elusive, despite the impressive pace by which the data on MS are accumulating. In this review, we will try to integrate the current facts and concepts, focusing on the role of redox changes and various reactive species in MS. Knowing the schedule of initial changes in pathogenic factors and the key turning points, as well as understanding the redox processes involved in MS pathogenesis is the way to enable MS prevention, early treatment, and the development of therapies that target specific pathophysiological components of the heterogeneous mechanisms of MS, which could alleviate the symptoms and hopefully stop MS. Pertinent to this, we will outline (i) redox processes involved in MS initiation; (ii) the role of reactive species in inflammation; (iii) prooxidative changes responsible for neurodegeneration; and (iv) the potential of antioxidative therapy. Antioxid. Redox Signal. 19, 2286-2334.",
publisher = "New Rochelle: Mary Ann Liebert, Inc.",
journal = "Antioxidants & Redox Signaling",
title = "Multiple Sclerosis: Molecular Mechanisms and Therapeutic Opportunities",
number = "18",
volume = "19",
doi = "10.1089/ars.2012.5068",
pages = "2286-2334",
url = "https://hdl.handle.net/21.15107/rcub_ibiss_937"
}
Miljković, Đ.,& Spasojević, I. B.. (2013). Multiple Sclerosis: Molecular Mechanisms and Therapeutic Opportunities. in Antioxidants & Redox Signaling
New Rochelle: Mary Ann Liebert, Inc.., 19(18), 2286-2334.
https://doi.org/10.1089/ars.2012.5068
https://hdl.handle.net/21.15107/rcub_ibiss_937
Miljković Đ, Spasojević IB. Multiple Sclerosis: Molecular Mechanisms and Therapeutic Opportunities. in Antioxidants & Redox Signaling. 2013;19(18):2286-2334.
doi:10.1089/ars.2012.5068
https://hdl.handle.net/21.15107/rcub_ibiss_937 .
Miljković, Đorđe, Spasojević, Ivan B, "Multiple Sclerosis: Molecular Mechanisms and Therapeutic Opportunities" in Antioxidants & Redox Signaling, 19, no. 18 (2013):2286-2334,
https://doi.org/10.1089/ars.2012.5068 .,
https://hdl.handle.net/21.15107/rcub_ibiss_937 .
5
97
41
96

Učestalost alela CCR5Δ32 u srpskoj populaciji

Đorđević, Valentina; Timotijević, Gordana; Pruner, Iva; Radojković, Dragica; Milovanović, Boško; Miljković, Đorđe

(2013)

TY  - JOUR
AU  - Đorđević, Valentina
AU  - Timotijević, Gordana
AU  - Pruner, Iva
AU  - Radojković, Dragica
AU  - Milovanović, Boško
AU  - Miljković, Đorđe
PY  - 2013
PY  - 2013
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/503
AB  - Background: The mutant CCR5Δ32 allele confers resistance to HIV infection. Several hypotheses regarding its origin and persistence in the human population have been proposed. It is assumed that the Δ32 mutation was introduced in Northern or Eastern Europe and that it spread to the south. Although the frequency of CCR5Δ32 was determined in numerous European nations and regions, further data are needed to complete the puzzle of CCR5Δ32 distribution within the continent. Methods: To this end, CCR5Δ32 frequency was determined in a Serbian population (sample size 352). DNA was extracted from peripheral whole blood and polymerase chain reaction specific for CCR5 gene was performed. A reaction product of 263 bp was obtained from the wild­type CCR5 sequence and a product of 231 bp was obtained from the truncated CCR5Δ32 sequence. Results: Overall allele frequency of CCR5Δ32 is 4.55%; 0.57% of individuals in the examined population are homozygous and 8.52% are heterozygous for CCR5Δ32. Conclusions: The determined frequency of the CCR5Δ32 allele in a Serbian population is unexpectedly low, considering ethnically related populations.
AB  - Uvod: Nosioci alela CCR5Δ32 su relativno rezistentni na infekciju HIV-om. Postoji nekoliko hipoteza o poreklu i održanju ovog alela u ljudskoj populaciji. Pretpostavlja se da je mutacija Δ32 nastala u populaciji severne ili istočne Evrope i da se potom proširila ka jugu. Iako je učestalost CCR5Δ32 određena u mnogim evropskim populacijama, dodatni podaci su neophodni za formiranje sveobuhvatne slike o distribuciji CCR5Δ32 u Evropi. Zbog toga smo u našoj studiji odredili učestalost CCR5Δ32 u srpskoj populaciji, za koju do ovog rada nisu postojali takvi podaci. Metode: DNK je izolovana iz periferne krvi 352 osobe. U reakciji lančanog umnožavanja korišćeni su prajmeri specifični za gen CCR5. Dobijen je proizvod od 263 bp na osnovu matrice 'wild type', sekvence CCR5 gena, a proizvod od 231 bp na osnovu okrnjene sekvence gena CCR5 (CCR5Δ32). Ukupna učestalost alela CCR5Δ32 u srpskoj populaciji iznosi 4,55%. Rezultati: Od ukupnog broja analiziranih osoba, identifikovano je 8,52% heterozigotnih i 0,57% homozigotnih nosilaca za ovaj alel. Zaključak: Utvrđena učestalost alela CCR5Δ32 u srpskoj populaciji je neočekivano niska, u poređenju sa učestalošću u ostalim slovenskim populacijama.
T2  - Journal of Medical Biochemistry
T1  - Učestalost alela CCR5Δ32 u srpskoj populaciji
T1  - The frequency of allele CCR5Δ32 in a Serbian population
IS  - 4
VL  - 32
DO  - 10.2478/jomb-2013-0030
SP  - 368
EP  - 374
ER  - 
@article{
author = "Đorđević, Valentina and Timotijević, Gordana and Pruner, Iva and Radojković, Dragica and Milovanović, Boško and Miljković, Đorđe",
year = "2013, 2013",
abstract = "Background: The mutant CCR5Δ32 allele confers resistance to HIV infection. Several hypotheses regarding its origin and persistence in the human population have been proposed. It is assumed that the Δ32 mutation was introduced in Northern or Eastern Europe and that it spread to the south. Although the frequency of CCR5Δ32 was determined in numerous European nations and regions, further data are needed to complete the puzzle of CCR5Δ32 distribution within the continent. Methods: To this end, CCR5Δ32 frequency was determined in a Serbian population (sample size 352). DNA was extracted from peripheral whole blood and polymerase chain reaction specific for CCR5 gene was performed. A reaction product of 263 bp was obtained from the wild­type CCR5 sequence and a product of 231 bp was obtained from the truncated CCR5Δ32 sequence. Results: Overall allele frequency of CCR5Δ32 is 4.55%; 0.57% of individuals in the examined population are homozygous and 8.52% are heterozygous for CCR5Δ32. Conclusions: The determined frequency of the CCR5Δ32 allele in a Serbian population is unexpectedly low, considering ethnically related populations., Uvod: Nosioci alela CCR5Δ32 su relativno rezistentni na infekciju HIV-om. Postoji nekoliko hipoteza o poreklu i održanju ovog alela u ljudskoj populaciji. Pretpostavlja se da je mutacija Δ32 nastala u populaciji severne ili istočne Evrope i da se potom proširila ka jugu. Iako je učestalost CCR5Δ32 određena u mnogim evropskim populacijama, dodatni podaci su neophodni za formiranje sveobuhvatne slike o distribuciji CCR5Δ32 u Evropi. Zbog toga smo u našoj studiji odredili učestalost CCR5Δ32 u srpskoj populaciji, za koju do ovog rada nisu postojali takvi podaci. Metode: DNK je izolovana iz periferne krvi 352 osobe. U reakciji lančanog umnožavanja korišćeni su prajmeri specifični za gen CCR5. Dobijen je proizvod od 263 bp na osnovu matrice 'wild type', sekvence CCR5 gena, a proizvod od 231 bp na osnovu okrnjene sekvence gena CCR5 (CCR5Δ32). Ukupna učestalost alela CCR5Δ32 u srpskoj populaciji iznosi 4,55%. Rezultati: Od ukupnog broja analiziranih osoba, identifikovano je 8,52% heterozigotnih i 0,57% homozigotnih nosilaca za ovaj alel. Zaključak: Utvrđena učestalost alela CCR5Δ32 u srpskoj populaciji je neočekivano niska, u poređenju sa učestalošću u ostalim slovenskim populacijama.",
journal = "Journal of Medical Biochemistry",
title = "Učestalost alela CCR5Δ32 u srpskoj populaciji, The frequency of allele CCR5Δ32 in a Serbian population",
number = "4",
volume = "32",
doi = "10.2478/jomb-2013-0030",
pages = "368-374"
}
Đorđević, V., Timotijević, G., Pruner, I., Radojković, D., Milovanović, B.,& Miljković, Đ.. (2013). Učestalost alela CCR5Δ32 u srpskoj populaciji. in Journal of Medical Biochemistry, 32(4), 368-374.
https://doi.org/10.2478/jomb-2013-0030
Đorđević V, Timotijević G, Pruner I, Radojković D, Milovanović B, Miljković Đ. Učestalost alela CCR5Δ32 u srpskoj populaciji. in Journal of Medical Biochemistry. 2013;32(4):368-374.
doi:10.2478/jomb-2013-0030 .
Đorđević, Valentina, Timotijević, Gordana, Pruner, Iva, Radojković, Dragica, Milovanović, Boško, Miljković, Đorđe, "Učestalost alela CCR5Δ32 u srpskoj populaciji" in Journal of Medical Biochemistry, 32, no. 4 (2013):368-374,
https://doi.org/10.2478/jomb-2013-0030 . .
1
1